**3. Methods and mechanisms for inducing a damage response in the absence of chromatin damage**

The induction of DNA damage repair pathways by exogenous DNA was first reported in bacteria, into which UV-irradiated lambda bacteriophages (D'Ari & Huisman, 1982; George et al., 1974) or plasmids (Bailone et al., 1984) were introduced. This indirect response is controlled by activation at the sites of exogenous DNA damage of the RecA protein, the key enzyme of the bacterial damage signaling response known as the "SOS response" (see Schlacher & Goodman (2007)). No such mechanism was initially found in mammals, despite a few publications reporting that UV-irradiated H-1 parvovirus or SV40 simian virus induced an "SOS-like" repair pathway in infected mammalian cells (Cornelis et al., 1982). Elucidation of the mechanisms underlying the response to damaged DNA or RNA in the cell took much longer in mammals. We review here the mammalian cell response to oligonucleotides, viral and immunostimulatory DNA and the insight into DDR gained from the analysis of artificial repair foci.

#### **3.1 Cellular response to DNA oligonucleotides**

10 Will-be-set-by-IN-TECH

The outcomes of DNA damage signaling are, literally, a matter of life or death. Depending on the severity of DNA damage, the cell will either repair the damage to enable it to continue dividing or enter apoptosis. Complex, redundant signaling pathways converging on several central node proteins have emerged to ensure that this signaling remains under tight control. These node proteins must obtain input signals from several sources, in the form of protein modifications, before they can relay the signal to downstream effectors. This has a protective effect, greatly reducing the risk of important cell fate decisions, such as entry into apoptosis, occurring in response to a single erroneous input signal (Yarosh, 2001). The nodes in DDR include checkpoint proteins, such as Chk1 and Chk2, which control cell cycling and require input signals from several sources for full activation (McAdams & Arkin, 1999). Another prominent example for a node protein in DNA damage signaling is p53 (Kohn, 1999). The p53 protein has 11 sites for phosphorylation and acetylation, and can theoretically assume about 2000 modification states, if all the possible independent combinations are taken into account. Twelve different kinases can phosphorylate p53, and activated p53 can interact with at least 15 downstream proteins (Yarosh, 2001). The kinases that phosphorylate p53 in response to DNA damage include DNA-PK, ATM and ATR. Full p53 activity requires phosphorylation by both DNA-PK and ATM, at least (Wang et al., 2000). It is therefore now thought that p53 plays a key role in determining the degree of damage, through the assessment of input signals, on which the decision as to whether apoptosis is necessary is based (Kohn, 1999). There is a need to determine the specific conditions under which individual PIKKs become activated. Which (genotoxic) stresses lead to the activation of all transducer kinases? Is it possible to activate a single PIKK specifically, without affecting the others, and what are the cellular consequences

There is also direct interplay between the transducer kinases (Chen et al., 2007). PIKKs can phosphorylate each other in response to DNA damage, resulting in mutual control of their activities. In addition to mediating posttranslational modifications, the kinases seem to regulate each other, either directly or indirectly (Peng et al., 2005). Studies on mutants and siRNA experiments have shown that a decrease in the amount of one of these kinases often leads to a decrease in the amounts of the PIKK sister kinases. The location of the kinases also seems to play an important role. For ATM, for example, the concentration of multiple copies in repair foci plays an important role in kinase activation, whereas DNA-PK does not need

Another layer of complexity is added by the partially overlapping substrate specificities of the transducers ATM, DNA-PK and ATR (reviewed by Durocher & Jackson (2001) and Yang et al. (2003)). These transducers signal different types of DNA damage, but it was recently shown that the PIKK-mediated signaling network is highly extensive, with hundreds of phosphorylation events at ATR, ATM and DNA-PK consensus target sites induced by IR (Matsuoka et al., 2007). As discussed above, the plethora of types of damage induced by IR results in the activation of all three PIKKs. It remains to be determined which substrates are specific or overlapping for which transducer kinases in this long list of potential PIKK targets. Further insight into the contributions of individual repair signaling pathways has been provided by studies of the responses induced by damage signals in the absence of

**2.5.2 Complexity of DNA damage response regulation**

such an accumulation of multiple copies for full activation.

chromatin damage. This aspect will be discussed below.

of this?

In bacteria, ssDNA has been identified as the signal triggering the bacterial SOS repair response. The RecA protein (Rad51 in humans) is directly stimulated by ssDNA, inactivating the LexA repressor and triggering the repair response (Craig & Roberts, 1981). It has been suggested that ssDNA (at SSBs, stalled replication forks or resected DSBs) acts also as the major stimulatory signal for DNA damage responses in eukaryotic cells (Li & Deshaies, 1993; Nur et al., 2003). Several studies based on transfection or the microinjection of synthetic DNA oligonucleotides have analyzed the response of the cell to ssDNA. Studies by Nur et al. (2003) have shown that ssDNA acts upstream from ATM/p53 in DNA damage signaling. The transfection of cells with short (as few as 5 bases) ssDNA molecules with random sequences induced ATM activation and apoptosis, whereas very short (8 bp) dsDNA molecules did not (Nur et al., 2003). The induction of apoptosis by ssDNA is consistent with earlier studies, in which transfection with randomly fragmented DNA (Schiavone et al., 2000) or the nuclear injection of linearized plasmid DNA, circular DNA containing a gap, or single-stranded circular phagemids induced cell cycle arrest or apoptosis (Huang et al., 1996). The activation of ATM by fragmented DNA requires the MRN-assisted assembly of short, linear ssDNA fragments into high-molecular weight complexes, as shown by experiments in *Xenopus laevis* extracts (Costanzo et al., 2004).

So, if ssDNA can activate ATM directly, how is ATM activated in response to DNA double-strand breaks? When DNA double-strand breaks are sensed by the MRN complex, MRN partially unwinds the ends to expose ssDNA (Lee & Paull, 2005). It has been shown in *Xenopus laevis* egg extracts that 70 bp synthetic double-stranded molecules are rapidly resected in an MRN-dependent manner to generate ssDNA oligonucleotides, which activate ATM (Jazayeri et al., 2008). Consistent with these findings, the injection of small synthetic ssDNA oligomers into undamaged cells also induces ATM activation, and the elimination of ssDNA oligomers results in the rapid extinction of ATM activity. In summary, the results obtained from experiments with single-stranded or long double-stranded DNA fragments suggest that short ssDNA molecules are the essential signal for the induction of ATM-dependent cell cycle arrest and apoptosis.

of the ways in which viral proteins can manipulate the host DNA repair machinery and cell cycle checkpoints, we refer the reader to Chaurushiya & Weitzman (2009), Davy & Doorbar

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 345

Adenoviruses (Ad), which belong to the parvovirus family, are probably the most thoroughly investigated DNA viruses. Their genome consists of a linear, 36 kb dsDNA molecule, with inverted terminal repeats (ITRs) at each end and origins for DNA replication (Weitzman & Ornelles, 2005). Viral proteins synthesized before viral DNA replication prevent the recognition of the Ad genome by host DNA repair factors. This may involve the targeting, by these proteins, of cellular damage sensors and repair effectors, such as the MRN complex or DNA ligase IV, for degradation and relocalization (Carson et al., 2003; Stracker et al., 2002). Infection with Ad lacking the proteins required for blockade of the host DNA repair machinery results in partial DDR activation. DNA damage mediator proteins accumulate at sites of viral replication (Stracker et al., 2002) and *γ*-H2AX is formed at the periphery of viral centers, in a process dependent on host cell PIKK activity (Carson et al., 2003). Despite the interference of viral proteins with the cellular DNA repair system during infection with wild-type Ad, the cellular DDR does not seem to be completely abolished. The foreign DNA induces H2AX phosphorylation during later stages of infection, after the onset of viral DNA replication (Nichols et al., 2009). H2AX phosphorylation follows a pan-nuclear pattern, suggesting that all the H2AX on the host chromatin is phosphorylated by ectopic kinase activation, contrasting with the localized *γ*-H2AX formation observed in response to DSBs in the chromatin. Viral replication seems to be required for this phosphorylation, because infection with a nonreplicating virus does not induce *γ*-H2AX (Nichols et al., 2009) production. ATR may be the principal kinase phosphorylating H2AX in these conditions,

although ATM and DNA-PK also seem to be involved (Nichols et al., 2009).

phosphorylation pattern was not investigated (Collaco et al., 2009).

Pan-nuclear H2AX phosphorylation has also been observed in cells infected with the adeno-associated virus (AAV) (Collaco et al., 2009; Fragkos et al., 2008; Schwartz et al., 2009). The AAV genome, like that of Ad, consists of an ssDNA molecule with ITRs at both ends, resulting in the formation of double-hairpin structures (Brown, 2010). AAV infection requires helper functions, which may be supplied by Ad or other viruses (Geoffroy & Salvetti, 2005), and components of the host cell DNA replication machinery (Nash et al., 2009). Viral replication takes place in the nucleus, where cellular proteins, including RPA, colocalize with viral proteins in replication centers (Stracker et al., 2004). AAV replication in the presence of minimal Ad helper proteins induces a robust DDR-like response. This response is independent of the MRN complex and seems to be mediated principally by DNA-PKcs and, to a lesser extent, by ATM (Collaco et al., 2009; Schwartz et al., 2009). The response involves the accumulation of DNA-PK in compartments in which viral replication is occurring, and the pan-nuclear phosphorylation, not only of H2AX, but also of Smc1 and ATM (Schwartz et al., 2009). In another study, the phosphorylation of RPA, Nbs1 and Chk1/2 was observed, but the

In addition to the DNA-PK-dependent DDR induced by AAV replication, studies on recombinant AAV (rAAV) vectors (Carter, 2004), have demonstrated the existence of a requirement for DNA-PKcs and Ku70/80 for viral DNA replication (Choi et al., 2010). The inactivation of DNA-PK by a DNA-PK inhibitor or siRNA significantly decreases the replication of rAAV, and any rAAV DNA that is replicated forms head-to-head or tail-to-tail

(2007) and Weitzman et al. (2004).

**3.3.1 DDR induction by DNA viruses**

The cellular response to single-stranded oligonucleotides may also have consequences for targeted gene repair with synthetic oligonucleotides. In gene targeting processes, ssDNA molecules are transported to the nucleus, where they align with their complementary sequence in the target gene, facilitating nucleotide exchange (Brachman & Kmiec, 2002). However, the introduction of large amounts of oligonucleotides into cells may induce cell cycle arrest and stalled DNA replication in the corrected cells, due to the ATM activation by the mechanism described above. Ferrara & Kmiec (2006) showed that the transfection of human colorectal cancer cells with 47-mer single-stranded oligonucleotides mostly activated Chk1 and Chk2 in corrected cells. As a consequence, uncorrected cells may outgrow corrected cells. The uncorrected cells probably contain fewer oligonucleotides, too few indeed to generate a local ssDNA concentration high enough to activate ATM. This may account for previous reports of the decline of corrected populations over time (Igoucheva et al., 2004).

#### **3.2 Synthetic interstrand crosslinks**

The cytotoxic activity of many chemotherapeutic agents, including cisplatin, nitrogen mustards and mitomycin C, is due to the induction of interstrand crosslinks (ICLs) in DNA. These lesions block the strand separation necessary for essential DNA functions, such as transcription and replication. ICLs affect both strands of the chromosome, and their repair is particularly complex. It involves factors from multiple repair pathways and the mechanisms may differ at different stages of the cell cycle. Nucleotide-excision repair, homologous recombination repair, the Fanconi anemia repair pathway, MMR and translesion synthesis have all been shown to participate in ICL repair.

Oligonucleotides containing synthetic ICLs are a valuable tool for the study of ICL repair (Guainazzi & Scharer, 2010). The advantage of such molecules over cell treatment with a cross-linking agent is that it is possible to study the components involved in the repair of specific interstrand crosslink products one at a time. This has mostly involved the ligation of the synthetic ICL-containing DNA fragments into plasmids, followed by analysis of their repair in cell-free extracts or cells (Orelli et al., 2010; Raschle et al., 2008; Wang et al., 2001). The repair of the specific ICL can be analyzed with reporter genes or by enzymatic digestion followed by Southern blotting. Studies with synthetic DNA ICLs have contributed to our understanding of the mechanism of replication-coupled DNA ICL repair (Wang et al., 2001) and the role of the Fanconi anemia pathway in this repair process (Knipscheer et al., 2009).

#### **3.3 Viral infection**

The highly organized cellular response to DNA damage may be disorganized or hijacked during viral infection (Lilley et al., 2007; Weitzman et al., 2004). Viruses often produce large amounts of exogenous DNA during infection, and generate proteins that interfere with DNA repair pathways and cell cycle checkpoints. Recent studies have suggested that the cellular DNA repair machinery can recognize viral nucleic acids as damage (Lilley et al., 2007). In some cases, the host DNA repair response is inactivated by viruses, whereas in others, the maintenance of a functional host DNA repair machinery seems to increase viral replication. Studies of the interaction of viruses with the host cell DNA repair machinery have improved our understanding of normal cellular DNA repair functions, and viruses may be useful model systems for studying certain aspects of DNA repair (Weitzman & Ornelles, 2005). In this section, we provide an overview of the ways in which viral infection can activate the DDR in cells, thereby focusing on the response to viral genomic material. For a detailed description of the ways in which viral proteins can manipulate the host DNA repair machinery and cell cycle checkpoints, we refer the reader to Chaurushiya & Weitzman (2009), Davy & Doorbar (2007) and Weitzman et al. (2004).

#### **3.3.1 DDR induction by DNA viruses**

12 Will-be-set-by-IN-TECH

The cellular response to single-stranded oligonucleotides may also have consequences for targeted gene repair with synthetic oligonucleotides. In gene targeting processes, ssDNA molecules are transported to the nucleus, where they align with their complementary sequence in the target gene, facilitating nucleotide exchange (Brachman & Kmiec, 2002). However, the introduction of large amounts of oligonucleotides into cells may induce cell cycle arrest and stalled DNA replication in the corrected cells, due to the ATM activation by the mechanism described above. Ferrara & Kmiec (2006) showed that the transfection of human colorectal cancer cells with 47-mer single-stranded oligonucleotides mostly activated Chk1 and Chk2 in corrected cells. As a consequence, uncorrected cells may outgrow corrected cells. The uncorrected cells probably contain fewer oligonucleotides, too few indeed to generate a local ssDNA concentration high enough to activate ATM. This may account for previous reports of the decline of corrected populations over time (Igoucheva et al., 2004).

The cytotoxic activity of many chemotherapeutic agents, including cisplatin, nitrogen mustards and mitomycin C, is due to the induction of interstrand crosslinks (ICLs) in DNA. These lesions block the strand separation necessary for essential DNA functions, such as transcription and replication. ICLs affect both strands of the chromosome, and their repair is particularly complex. It involves factors from multiple repair pathways and the mechanisms may differ at different stages of the cell cycle. Nucleotide-excision repair, homologous recombination repair, the Fanconi anemia repair pathway, MMR and translesion synthesis

Oligonucleotides containing synthetic ICLs are a valuable tool for the study of ICL repair (Guainazzi & Scharer, 2010). The advantage of such molecules over cell treatment with a cross-linking agent is that it is possible to study the components involved in the repair of specific interstrand crosslink products one at a time. This has mostly involved the ligation of the synthetic ICL-containing DNA fragments into plasmids, followed by analysis of their repair in cell-free extracts or cells (Orelli et al., 2010; Raschle et al., 2008; Wang et al., 2001). The repair of the specific ICL can be analyzed with reporter genes or by enzymatic digestion followed by Southern blotting. Studies with synthetic DNA ICLs have contributed to our understanding of the mechanism of replication-coupled DNA ICL repair (Wang et al., 2001) and the role of the Fanconi anemia pathway in this repair process (Knipscheer et al., 2009).

The highly organized cellular response to DNA damage may be disorganized or hijacked during viral infection (Lilley et al., 2007; Weitzman et al., 2004). Viruses often produce large amounts of exogenous DNA during infection, and generate proteins that interfere with DNA repair pathways and cell cycle checkpoints. Recent studies have suggested that the cellular DNA repair machinery can recognize viral nucleic acids as damage (Lilley et al., 2007). In some cases, the host DNA repair response is inactivated by viruses, whereas in others, the maintenance of a functional host DNA repair machinery seems to increase viral replication. Studies of the interaction of viruses with the host cell DNA repair machinery have improved our understanding of normal cellular DNA repair functions, and viruses may be useful model systems for studying certain aspects of DNA repair (Weitzman & Ornelles, 2005). In this section, we provide an overview of the ways in which viral infection can activate the DDR in cells, thereby focusing on the response to viral genomic material. For a detailed description

**3.2 Synthetic interstrand crosslinks**

**3.3 Viral infection**

have all been shown to participate in ICL repair.

Adenoviruses (Ad), which belong to the parvovirus family, are probably the most thoroughly investigated DNA viruses. Their genome consists of a linear, 36 kb dsDNA molecule, with inverted terminal repeats (ITRs) at each end and origins for DNA replication (Weitzman & Ornelles, 2005). Viral proteins synthesized before viral DNA replication prevent the recognition of the Ad genome by host DNA repair factors. This may involve the targeting, by these proteins, of cellular damage sensors and repair effectors, such as the MRN complex or DNA ligase IV, for degradation and relocalization (Carson et al., 2003; Stracker et al., 2002). Infection with Ad lacking the proteins required for blockade of the host DNA repair machinery results in partial DDR activation. DNA damage mediator proteins accumulate at sites of viral replication (Stracker et al., 2002) and *γ*-H2AX is formed at the periphery of viral centers, in a process dependent on host cell PIKK activity (Carson et al., 2003). Despite the interference of viral proteins with the cellular DNA repair system during infection with wild-type Ad, the cellular DDR does not seem to be completely abolished. The foreign DNA induces H2AX phosphorylation during later stages of infection, after the onset of viral DNA replication (Nichols et al., 2009). H2AX phosphorylation follows a pan-nuclear pattern, suggesting that all the H2AX on the host chromatin is phosphorylated by ectopic kinase activation, contrasting with the localized *γ*-H2AX formation observed in response to DSBs in the chromatin. Viral replication seems to be required for this phosphorylation, because infection with a nonreplicating virus does not induce *γ*-H2AX (Nichols et al., 2009) production. ATR may be the principal kinase phosphorylating H2AX in these conditions, although ATM and DNA-PK also seem to be involved (Nichols et al., 2009).

Pan-nuclear H2AX phosphorylation has also been observed in cells infected with the adeno-associated virus (AAV) (Collaco et al., 2009; Fragkos et al., 2008; Schwartz et al., 2009). The AAV genome, like that of Ad, consists of an ssDNA molecule with ITRs at both ends, resulting in the formation of double-hairpin structures (Brown, 2010). AAV infection requires helper functions, which may be supplied by Ad or other viruses (Geoffroy & Salvetti, 2005), and components of the host cell DNA replication machinery (Nash et al., 2009). Viral replication takes place in the nucleus, where cellular proteins, including RPA, colocalize with viral proteins in replication centers (Stracker et al., 2004). AAV replication in the presence of minimal Ad helper proteins induces a robust DDR-like response. This response is independent of the MRN complex and seems to be mediated principally by DNA-PKcs and, to a lesser extent, by ATM (Collaco et al., 2009; Schwartz et al., 2009). The response involves the accumulation of DNA-PK in compartments in which viral replication is occurring, and the pan-nuclear phosphorylation, not only of H2AX, but also of Smc1 and ATM (Schwartz et al., 2009). In another study, the phosphorylation of RPA, Nbs1 and Chk1/2 was observed, but the phosphorylation pattern was not investigated (Collaco et al., 2009).

In addition to the DNA-PK-dependent DDR induced by AAV replication, studies on recombinant AAV (rAAV) vectors (Carter, 2004), have demonstrated the existence of a requirement for DNA-PKcs and Ku70/80 for viral DNA replication (Choi et al., 2010). The inactivation of DNA-PK by a DNA-PK inhibitor or siRNA significantly decreases the replication of rAAV, and any rAAV DNA that is replicated forms head-to-head or tail-to-tail

apoptosis (Dahl et al., 2005; Kudoh et al., 2005). By contrast, the autonomous minute virus of canines (MVC), a member of the parvovirus family, induces apoptosis and G(2)/M-phase arrest in infected canine cells (Chen et al., 2010). This seems to be the result of the induction of an ATM/p53-mediated DDR (Luo et al., 2011). Infected cells display phosphorylation of H2AX, RPA, ATM and ATR. The inhibition or knockdown of ATM decreased cell death and

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 347

In summary, studies of the response of the cell to viral genomic material have demonstrated that the activation of a damage response involving ATM (e.g. in the case of MVC) or ATR (UV-inactivated rAAV) leads to cell cycle arrest or p53-dependent cell death, unless downstream effectors are inactivated or sequestered by viral proteins (HSV-1, HCMV). By contrast, DNA-PK activation (Ad, AAV) leads to pan-nuclear H2AX phosphorylation, which does not seem to be detrimental to the cell. These findings have possible consequences for the choice of viral vectors for gene targeting. It remains to be determined whether the "ectopic" phosphorylation of DNA-PK downstream targets affects the stability of the host cell genome or impairs DNA repair in infected cells. It has also been shown that the specific recruitment of a subset of cellular DNA repair factors is essential for viral DNA replication, suggesting that

Interaction with the cellular DNA damage sensing machinery is not limited to DNA viruses. Retroviruses, which contain a single-stranded RNA genome, use a viral-encoded reverse transcriptase to generate a cDNA that is then integrated into the host genome. The preintegration complex contains the cDNA and the viral-encoded integrase enzyme. This enzyme then mediates strand transfer to integrate the viral DNA into the host DNA in a non site-specific fashion (Weitzman et al., 2004). The interaction of retroviruses with the cellular DNA repair machinery has been studied in detail (Lilley et al., 2007; Sakurai et al., 2009; Skalka & Katz, 2005). The NHEJ pathway has been implicated in the sensing and processing of the linear cDNA, although the exact step of the viral life-cycle affected by the cellular DNA repair machinery remains unclear Ariumi et al. (2005). It is possible that the viral cDNA acts directly as a substrate for NHEJ, which circularizes the DNA by end ligation (Li et al., 2001). The circularization of unintegrated DNA in this context may protect the viral DNA from degradation and the cell from apoptosis (Kilzer et al., 2003). Consistent with this hypothesis, the infection with retrovirus of cells lacking NHEJ factors results in apoptosis, suggesting that DNA-PKcs and Ku70/80 may protect against the cellular toxicity of high levels of retroviral

Another interaction of retroviruses with the DNA repair machinery is constituted by the role of cellular repair and damage signaling factors in the integration of viral DNA into the host genome (Daniel et al., 1999). During retroviral integration, DSBs are created as an intermediate that may be detected as DNA damage by the host cell (Sakurai et al., 2009). Transient phosphorylation of histone H2AX occurs at retroviral integration sites, and it has been suggested that the completion of the integration process is dependent on DNA-PK (Daniel et al., 1999; 2004). DNA-PK-deficient mouse scid cells infected with three different retroviruses display much lower levels of DNA integration than wild-type cells and die by apoptosis. Furthermore, it has been reported that DNA-PKcs is required for efficient transduction by retroviral vectors (Daniel et al., 1999). Other PIKKs have since been shown to be activated after HIV-1 infection and to play a potential role in provirus integration. The use

reduced MVC DNA replication.

cDNA (Li et al., 2001).

inhibitors targeting these proteins may have antiviral activity.

**3.3.2 DNA damage signals induced by retroviruses**

junctions. Moreover, AAV-ITRs interact directly with Ku proteins, suggesting that viral DNA is recognized directly by cellular NHEJ factors (Choi et al., 2010). Furthermore, DNA-PKcs and Artemis have been shown to open the ITR hairpin loops of rAAV *in vivo*, in a tissue-dependent manner. In the absence of either of these factors, double-stranded linear rAAV genomes capped with covalently closed hairpins at their termini accumulate in cells (Inagaki et al., 2007), confirming the importance of host cell NHEJ proteins for viral DNA end processing. By contrast to the "hyperactivation" of DNA-PK observed in response to replicating AAV, the DNA of UV-inactivated AAV particles activates a DDR involving ATM and ATR, leading to the inhibition of cell cycle progression (Jurvansuu et al., 2005). It has been suggested that the UV-treated DNA mimics stalled replication forks (Jurvansuu et al., 2005), whereas DNA-PK activation is consistent with the presence of DSBs as intermediate products during AAV replication.

DNA-PKcs and Ku70/80 as well as other cellular repair or replication factors including Topoisomerases I and II, MSH2-MSH6, RecQL, PARP and scaffold attachment factor A (SAF-A) are involved in Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication (Wang et al., 2008). KSHV is a large dsDNA virus and the etiologic agent of several AIDS-associated cancers, including Kaposi's sarcoma (Antman & Chang, 2000). The lytic replication of KSHV and the continuous primary infection of fresh cells are responsible for viral tumorigenicity and pathogenesis, by contrast to what has been reported for other oncogenic viruses (Grundhoff & Ganem, 2004). The proteins listed above bind to KSHV DNA fragments and accumulate in viral replication compartments in the nucleus, suggesting a possible role for these host replication and repair proteins in the viral lytic replication process (Wang et al., 2008).

In the case of infection with herpes simplex virus type 1 (HSV-1), which contains a linear dsDNA molecule, a DNA damage signaling is induced which depends principally on ATR (Lilley et al., 2005; Wilkinson & Weller, 2006). Several members of the cellular DNA damage-sensing machinery, including RPA, RAD51 and Nbs1, are activated and redistributed during viral DNA replication, indicating that infection induces the host response to DNA damage. H2AX is phosphorylated but the *γ*-H2AX signal is marginalized to the periphery of viral replication centers (Wilkinson & Weller, 2006). HSV-1 sequesters hyperphosphorylated RPA away from viral replication compartments, thus preventing a normal ATR-signaling response. The partial and mislocalized activation of the cellular DDR leads ultimately to its disorganization.

ATR is also activated during viral replication of the dsDNA virus human cytomegalovirus (HCMV), leading to an induction of *γ*-H2AX (Luo et al., 2007). Contrary to what has been observed for HSV-1, *γ*-H2AX co-localizes with viral replication compartments during late-stage infections with HCMV. Only a subset of proteins in addition to *γ*-H2AX was specifically sequestered in viral replication centers, with other proteins excluded from these centers, impeding both the efficient repair of viral DNA and checkpoint activation (Luo et al., 2007).

ATM-dependent checkpoint signaling takes place during induction of Epstein Barr virus lytic replication (Kudoh et al., 2005) or polyomavirus replication (Dahl et al., 2005). This is accompanied by the phosphorylation of a number of DNA damage markers including H2AX. The cellular ATM activation in response to both viruses leads to a prolonged S-phase advantageous for viral lytic replication. However, both viruses have developed efficient strategies to block ATM-induced p53 downstream signaling that would eventually lead to 14 Will-be-set-by-IN-TECH

junctions. Moreover, AAV-ITRs interact directly with Ku proteins, suggesting that viral DNA is recognized directly by cellular NHEJ factors (Choi et al., 2010). Furthermore, DNA-PKcs and Artemis have been shown to open the ITR hairpin loops of rAAV *in vivo*, in a tissue-dependent manner. In the absence of either of these factors, double-stranded linear rAAV genomes capped with covalently closed hairpins at their termini accumulate in cells (Inagaki et al., 2007), confirming the importance of host cell NHEJ proteins for viral DNA end processing. By contrast to the "hyperactivation" of DNA-PK observed in response to replicating AAV, the DNA of UV-inactivated AAV particles activates a DDR involving ATM and ATR, leading to the inhibition of cell cycle progression (Jurvansuu et al., 2005). It has been suggested that the UV-treated DNA mimics stalled replication forks (Jurvansuu et al., 2005), whereas DNA-PK activation is consistent with the presence of DSBs as intermediate products

DNA-PKcs and Ku70/80 as well as other cellular repair or replication factors including Topoisomerases I and II, MSH2-MSH6, RecQL, PARP and scaffold attachment factor A (SAF-A) are involved in Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication (Wang et al., 2008). KSHV is a large dsDNA virus and the etiologic agent of several AIDS-associated cancers, including Kaposi's sarcoma (Antman & Chang, 2000). The lytic replication of KSHV and the continuous primary infection of fresh cells are responsible for viral tumorigenicity and pathogenesis, by contrast to what has been reported for other oncogenic viruses (Grundhoff & Ganem, 2004). The proteins listed above bind to KSHV DNA fragments and accumulate in viral replication compartments in the nucleus, suggesting a possible role for these host replication and repair proteins in the viral lytic replication process

In the case of infection with herpes simplex virus type 1 (HSV-1), which contains a linear dsDNA molecule, a DNA damage signaling is induced which depends principally on ATR (Lilley et al., 2005; Wilkinson & Weller, 2006). Several members of the cellular DNA damage-sensing machinery, including RPA, RAD51 and Nbs1, are activated and redistributed during viral DNA replication, indicating that infection induces the host response to DNA damage. H2AX is phosphorylated but the *γ*-H2AX signal is marginalized to the periphery of viral replication centers (Wilkinson & Weller, 2006). HSV-1 sequesters hyperphosphorylated RPA away from viral replication compartments, thus preventing a normal ATR-signaling response. The partial and mislocalized activation of the cellular DDR leads ultimately to its

ATR is also activated during viral replication of the dsDNA virus human cytomegalovirus (HCMV), leading to an induction of *γ*-H2AX (Luo et al., 2007). Contrary to what has been observed for HSV-1, *γ*-H2AX co-localizes with viral replication compartments during late-stage infections with HCMV. Only a subset of proteins in addition to *γ*-H2AX was specifically sequestered in viral replication centers, with other proteins excluded from these centers, impeding both the efficient repair of viral DNA and checkpoint activation (Luo et al.,

ATM-dependent checkpoint signaling takes place during induction of Epstein Barr virus lytic replication (Kudoh et al., 2005) or polyomavirus replication (Dahl et al., 2005). This is accompanied by the phosphorylation of a number of DNA damage markers including H2AX. The cellular ATM activation in response to both viruses leads to a prolonged S-phase advantageous for viral lytic replication. However, both viruses have developed efficient strategies to block ATM-induced p53 downstream signaling that would eventually lead to

during AAV replication.

(Wang et al., 2008).

disorganization.

2007).

apoptosis (Dahl et al., 2005; Kudoh et al., 2005). By contrast, the autonomous minute virus of canines (MVC), a member of the parvovirus family, induces apoptosis and G(2)/M-phase arrest in infected canine cells (Chen et al., 2010). This seems to be the result of the induction of an ATM/p53-mediated DDR (Luo et al., 2011). Infected cells display phosphorylation of H2AX, RPA, ATM and ATR. The inhibition or knockdown of ATM decreased cell death and reduced MVC DNA replication.

In summary, studies of the response of the cell to viral genomic material have demonstrated that the activation of a damage response involving ATM (e.g. in the case of MVC) or ATR (UV-inactivated rAAV) leads to cell cycle arrest or p53-dependent cell death, unless downstream effectors are inactivated or sequestered by viral proteins (HSV-1, HCMV). By contrast, DNA-PK activation (Ad, AAV) leads to pan-nuclear H2AX phosphorylation, which does not seem to be detrimental to the cell. These findings have possible consequences for the choice of viral vectors for gene targeting. It remains to be determined whether the "ectopic" phosphorylation of DNA-PK downstream targets affects the stability of the host cell genome or impairs DNA repair in infected cells. It has also been shown that the specific recruitment of a subset of cellular DNA repair factors is essential for viral DNA replication, suggesting that inhibitors targeting these proteins may have antiviral activity.

#### **3.3.2 DNA damage signals induced by retroviruses**

Interaction with the cellular DNA damage sensing machinery is not limited to DNA viruses. Retroviruses, which contain a single-stranded RNA genome, use a viral-encoded reverse transcriptase to generate a cDNA that is then integrated into the host genome. The preintegration complex contains the cDNA and the viral-encoded integrase enzyme. This enzyme then mediates strand transfer to integrate the viral DNA into the host DNA in a non site-specific fashion (Weitzman et al., 2004). The interaction of retroviruses with the cellular DNA repair machinery has been studied in detail (Lilley et al., 2007; Sakurai et al., 2009; Skalka & Katz, 2005). The NHEJ pathway has been implicated in the sensing and processing of the linear cDNA, although the exact step of the viral life-cycle affected by the cellular DNA repair machinery remains unclear Ariumi et al. (2005). It is possible that the viral cDNA acts directly as a substrate for NHEJ, which circularizes the DNA by end ligation (Li et al., 2001). The circularization of unintegrated DNA in this context may protect the viral DNA from degradation and the cell from apoptosis (Kilzer et al., 2003). Consistent with this hypothesis, the infection with retrovirus of cells lacking NHEJ factors results in apoptosis, suggesting that DNA-PKcs and Ku70/80 may protect against the cellular toxicity of high levels of retroviral cDNA (Li et al., 2001).

Another interaction of retroviruses with the DNA repair machinery is constituted by the role of cellular repair and damage signaling factors in the integration of viral DNA into the host genome (Daniel et al., 1999). During retroviral integration, DSBs are created as an intermediate that may be detected as DNA damage by the host cell (Sakurai et al., 2009). Transient phosphorylation of histone H2AX occurs at retroviral integration sites, and it has been suggested that the completion of the integration process is dependent on DNA-PK (Daniel et al., 1999; 2004). DNA-PK-deficient mouse scid cells infected with three different retroviruses display much lower levels of DNA integration than wild-type cells and die by apoptosis. Furthermore, it has been reported that DNA-PKcs is required for efficient transduction by retroviral vectors (Daniel et al., 1999). Other PIKKs have since been shown to be activated after HIV-1 infection and to play a potential role in provirus integration. The use

ATM-dependent phosphorylation of H2AX during M-phase has been reported to occur in the absence of DNA damage (Ichijima et al., 2005; Mazumdar et al., 2006). The high degree of compaction of mitotic chromosomes may be the signal responsible for activating DNA damage signaling kinases in the absence of apparent DNA lesions (Ichijima et al., 2005). Another recent study showed that DNA-damage signaling pathways and ATM could be activated directly by hypoxia, apparently in the absence of lesions (Bencokova et al., 2009). The direct mechanism involved is unknown, but the hypoxia-induced activation of ATM is independent of the MRN complex, and active, autophosphorylated ATM has a pan-nuclear rather than focal distribution. The activation of ATM signaling in response to hypoxia may

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 349

ATM is a also a direct sensor of oxidative stress, in the absence of DNA lesions. Oxidation by ROS results in the formation of an active, disulfide-cross-linked, ATM dimer (Guo et al., 2010). The activation of ATM in response to oxidative stress is independent of the MRN complex and leads to the phosphorylation of DDR effectors including p53 and Chk2, but not the chromatin-associated proteins H2AX or Kap1. This confirms that ATM activation through oxidation may occur without the involvement of the DNA damage recognition machinery. Consistent with ATM activation, the transducer kinase ATR can also be activated in the absence of DNA damage. Toledo et al. (2008) reported the ectopic activation of ATR following overproduction of a fragment of TopBP1 containing a domain known to stimulate ATR kinase activity (Kumagai et al., 2006). ATR activation was sufficient to drive cell cycle arrest and

DNA fragments trigger a DDR at the cellular level, but the detection of foreign DNA by specific sensors can trigger an innate immune response at the systemic level (for review see Vilaysane & Muruve (2009), Yanai et al. (2009) and Rathinam & Fitzgerald (2011)). The innate immune system is an integral part of the host response to viral and bacterial intrusion. Its activation leads to diverse cellular responses, including the induction of interferon regulatory factors (IRF) 3 and 7, which regulate the production of type I interferon. Furthermore, NF*κ*B is induced, and regulates the expression of pro-inflammatory cytokines (Vilaysane & Muruve, 2009). We provide here a brief overview of the principal sensors of foreign DNA found in

Bacterial DNA differs from mammalian DNA principally in terms of its high CpG dinucleotide content. Furthermore, most of the small number of CpG dinucleotides present in mammalian DNA are methylated, whereas the CpG dinucleotides in bacterial DNA are generally unmethylated (Hemmi et al., 2000). The activation of innate immune responses by nucleic acids is mediated by transmembrane Toll-like receptors (TLRs) and cytosolic receptors. The best understood sensor of microbial DNA is TLR9, which is found principally in plasmacytoid dendritic cells (pDCs) in humans (Hemmi et al., 2000; Wagner, 2004). The endosomal uptake of CpG DNA activates TLR9, which binds MyD88, IRAK4 and IRAK1 that are required for the activation of NF*κ*B and the induction of type I interferons via IRF7 (Akira et al., 2006; Vilaysane & Muruve, 2009). Several studies have also shown that, in addition to responding to bacterial DNA, TLR9 plays an important role in host defense against viruses, including DNA viruses such as herpes simplex virus and murine cytomegalovirus (Delale

account for the cessation of replication when oxygen levels are low.

senescence.

humans.

**3.6 Systemic response to foreign DNA**

et al., 2005; Lund et al., 2003).

of caffeine or a small-molecule inhibitor to block the ATM activity results in the inhibition of HIV transduction and replication (Daniel et al., 2005; Lau et al., 2005).

DNA-PK and ATM also seem to be important for correct end processing at the junctions between HIV-1 provirus and host DNA (Sakurai et al., 2009). Large numbers of abnormal junctions are observed in Mre11- and DNA-PKcs-deficient cells, and Artemis-deficient cells also display such abnormalities, suggesting a role for NHEJ processing factors in correct viral integration. Another study has reported a role for Ku70/80 in the targeting of retroviral elements to chromatin domains prone to gene silencing. Higher levels of viral DNA expression are observed in the absence of Ku70/80, with no effect on viral transduction (Masson et al., 2007).

The importance of cellular components of the DDR for the replication of some viruses could be exploited for therapeutic purposes. For instance, a small-molecule ATM-inhibitor displayed antiviral activity in a proof-of-concept study with HIV-1, in which ATM deficiency sensitized cells to retrovirus-induced cell death (Lau et al., 2005).

#### **3.4 Tethering of repair factors**

Recent studies in yeast and mammals have demonstrated that it is not the DNA lesion that triggers the DDR, leading to the activation of transducer kinases, but the local concentration of signaling factors at repair foci. Soutoglou & Misteli (2008) demonstrated that a DDR can be triggered in the absence of DNA lesions. The artificial localized tethering of repair factors was found to be sufficient to trigger a full DDR response, including cell-cycle arrest, in the absence of DNA breaks. Tethering was achieved by fusing repair proteins to the *Escherichia coli lac* repressor and expressing the resulting constructs in mouse NIH-3T3 cells containing multiple *lacR* binding sites, stably integrated into the genome (Soutoglou & Misteli, 2008). The immobilization of Nbs1, Mre11 or MDC1 alone led to DDR activation. In addition, the tethering of ATM was sufficient to induce ATM kinase activity and autophosphorylation. Consistent with its function downstream from the MRN complex, the induction of ATM activity was not affected by an absence of Mre11 or Nbs1. As similar results were obtained in analogous experiments in *Saccharomyces cerevisiae* (Bonilla et al., 2008), the concentration of key factors on the chromatin may be considered a universal characteristic of DDR initiation and amplification in eukaryotes (Misteli & Soutoglou, 2009). The tethering experiments may be seen as complementary to the experiments with siDNA described below, as the DNA break-mimicking DNA molecules are (i) too short for the formation of repair foci and (ii) not in a chromatin context.

#### **3.5 DDR induction by cofactors, oxidative stress or changes in chromatin state**

ATM, and consequently the DDR, can be activated in the absence of DNA breaks, by changes in chromatin structure. Bakkenist & Kastan (2003) showed that ATM is rapidly activated by the exposure of cells to chromatin-active agents, such as mild hypotonic buffers, or treatment with chloroquine. Furthermore, histone deacetylase (HDAC) inhibitors, such as TSA, which induces the global decondensation of chromatin, can also induce ATM activity (Jang et al., 2010; Mazumdar et al., 2006). Consistent with its role as a sensor of chromatin structure, ATM can interact with the chromatin via the nucleosome-binding protein HMGN1 before DNA damage occurs. The loss of this interaction in the absence of HMGN1 compromises ATM activation in response to IR (Kim et al., 2009).

ATM-dependent phosphorylation of H2AX during M-phase has been reported to occur in the absence of DNA damage (Ichijima et al., 2005; Mazumdar et al., 2006). The high degree of compaction of mitotic chromosomes may be the signal responsible for activating DNA damage signaling kinases in the absence of apparent DNA lesions (Ichijima et al., 2005).

Another recent study showed that DNA-damage signaling pathways and ATM could be activated directly by hypoxia, apparently in the absence of lesions (Bencokova et al., 2009). The direct mechanism involved is unknown, but the hypoxia-induced activation of ATM is independent of the MRN complex, and active, autophosphorylated ATM has a pan-nuclear rather than focal distribution. The activation of ATM signaling in response to hypoxia may account for the cessation of replication when oxygen levels are low.

ATM is a also a direct sensor of oxidative stress, in the absence of DNA lesions. Oxidation by ROS results in the formation of an active, disulfide-cross-linked, ATM dimer (Guo et al., 2010). The activation of ATM in response to oxidative stress is independent of the MRN complex and leads to the phosphorylation of DDR effectors including p53 and Chk2, but not the chromatin-associated proteins H2AX or Kap1. This confirms that ATM activation through oxidation may occur without the involvement of the DNA damage recognition machinery.

Consistent with ATM activation, the transducer kinase ATR can also be activated in the absence of DNA damage. Toledo et al. (2008) reported the ectopic activation of ATR following overproduction of a fragment of TopBP1 containing a domain known to stimulate ATR kinase activity (Kumagai et al., 2006). ATR activation was sufficient to drive cell cycle arrest and senescence.

#### **3.6 Systemic response to foreign DNA**

16 Will-be-set-by-IN-TECH

of caffeine or a small-molecule inhibitor to block the ATM activity results in the inhibition of

DNA-PK and ATM also seem to be important for correct end processing at the junctions between HIV-1 provirus and host DNA (Sakurai et al., 2009). Large numbers of abnormal junctions are observed in Mre11- and DNA-PKcs-deficient cells, and Artemis-deficient cells also display such abnormalities, suggesting a role for NHEJ processing factors in correct viral integration. Another study has reported a role for Ku70/80 in the targeting of retroviral elements to chromatin domains prone to gene silencing. Higher levels of viral DNA expression are observed in the absence of Ku70/80, with no effect on viral transduction

The importance of cellular components of the DDR for the replication of some viruses could be exploited for therapeutic purposes. For instance, a small-molecule ATM-inhibitor displayed antiviral activity in a proof-of-concept study with HIV-1, in which ATM deficiency sensitized

Recent studies in yeast and mammals have demonstrated that it is not the DNA lesion that triggers the DDR, leading to the activation of transducer kinases, but the local concentration of signaling factors at repair foci. Soutoglou & Misteli (2008) demonstrated that a DDR can be triggered in the absence of DNA lesions. The artificial localized tethering of repair factors was found to be sufficient to trigger a full DDR response, including cell-cycle arrest, in the absence of DNA breaks. Tethering was achieved by fusing repair proteins to the *Escherichia coli lac* repressor and expressing the resulting constructs in mouse NIH-3T3 cells containing multiple *lacR* binding sites, stably integrated into the genome (Soutoglou & Misteli, 2008). The immobilization of Nbs1, Mre11 or MDC1 alone led to DDR activation. In addition, the tethering of ATM was sufficient to induce ATM kinase activity and autophosphorylation. Consistent with its function downstream from the MRN complex, the induction of ATM activity was not affected by an absence of Mre11 or Nbs1. As similar results were obtained in analogous experiments in *Saccharomyces cerevisiae* (Bonilla et al., 2008), the concentration of key factors on the chromatin may be considered a universal characteristic of DDR initiation and amplification in eukaryotes (Misteli & Soutoglou, 2009). The tethering experiments may be seen as complementary to the experiments with siDNA described below, as the DNA break-mimicking DNA molecules are (i) too short for the formation of repair foci and (ii) not

**3.5 DDR induction by cofactors, oxidative stress or changes in chromatin state**

ATM, and consequently the DDR, can be activated in the absence of DNA breaks, by changes in chromatin structure. Bakkenist & Kastan (2003) showed that ATM is rapidly activated by the exposure of cells to chromatin-active agents, such as mild hypotonic buffers, or treatment with chloroquine. Furthermore, histone deacetylase (HDAC) inhibitors, such as TSA, which induces the global decondensation of chromatin, can also induce ATM activity (Jang et al., 2010; Mazumdar et al., 2006). Consistent with its role as a sensor of chromatin structure, ATM can interact with the chromatin via the nucleosome-binding protein HMGN1 before DNA damage occurs. The loss of this interaction in the absence of HMGN1 compromises ATM

HIV transduction and replication (Daniel et al., 2005; Lau et al., 2005).

cells to retrovirus-induced cell death (Lau et al., 2005).

(Masson et al., 2007).

**3.4 Tethering of repair factors**

in a chromatin context.

activation in response to IR (Kim et al., 2009).

DNA fragments trigger a DDR at the cellular level, but the detection of foreign DNA by specific sensors can trigger an innate immune response at the systemic level (for review see Vilaysane & Muruve (2009), Yanai et al. (2009) and Rathinam & Fitzgerald (2011)). The innate immune system is an integral part of the host response to viral and bacterial intrusion. Its activation leads to diverse cellular responses, including the induction of interferon regulatory factors (IRF) 3 and 7, which regulate the production of type I interferon. Furthermore, NF*κ*B is induced, and regulates the expression of pro-inflammatory cytokines (Vilaysane & Muruve, 2009). We provide here a brief overview of the principal sensors of foreign DNA found in humans.

Bacterial DNA differs from mammalian DNA principally in terms of its high CpG dinucleotide content. Furthermore, most of the small number of CpG dinucleotides present in mammalian DNA are methylated, whereas the CpG dinucleotides in bacterial DNA are generally unmethylated (Hemmi et al., 2000). The activation of innate immune responses by nucleic acids is mediated by transmembrane Toll-like receptors (TLRs) and cytosolic receptors. The best understood sensor of microbial DNA is TLR9, which is found principally in plasmacytoid dendritic cells (pDCs) in humans (Hemmi et al., 2000; Wagner, 2004). The endosomal uptake of CpG DNA activates TLR9, which binds MyD88, IRAK4 and IRAK1 that are required for the activation of NF*κ*B and the induction of type I interferons via IRF7 (Akira et al., 2006; Vilaysane & Muruve, 2009). Several studies have also shown that, in addition to responding to bacterial DNA, TLR9 plays an important role in host defense against viruses, including DNA viruses such as herpes simplex virus and murine cytomegalovirus (Delale et al., 2005; Lund et al., 2003).

and repair. We recently tried to overcome these problems by proposing the use of a new class of small molecules (siDNA, for small interfering DNA) each mimicking one particular type of

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 351

We initially designed and tested only a few classes of siDNA molecules, to provide proof-of-concept for this approach. However, this concept can be extended to any specific type of damage. An siDNA is a small nucleic acid molecule carrying a modification recognized as a lesion by the sensor and transducer proteins. In addition to mimicking a specific type of damage, siDNA molecules must (i) be resistant to the action of nucleases, (ii) be as small as possible, to minimize the formation of secondary structures or degradation products, (iii) have no specific sequence likely to be recognized by DNA-binding proteins, such as transcription factors, (iv) mimic one single type of damage, ideally one that cannot be processed and (v) be recognized by at least one molecule involved in the DDR. SiDNAs are oligonucleotides chemically synthesized on solid support, by cycles of nucleotide addition. They are protected from exonuclease degradation by three phosphorothioate groups at the free 3' and 5' ends. Most siDNA molecules are double-stranded and have a specific modification characteristic of one type of damage. Dissociation of the short duplex is prevented by a linker tethering the two complementary strands at one or both ends of the molecule. The linker molecule

Fig. 4. Structure of the DSB-mimicking Dbait. Dbait 32Hc is a 32 bp DNA molecule tethered to its complementary sequence by a hexaethylene glycol loop (blue half circle) at one end and protected against exonuclease by phosphorothioate nucleotides (asterisks, phosphorothioate bond highlighted in red) at the other end. In the name 32Hc, H stands for hexaethylene glycol and c refers to the sequence. The sequence is not important for recognition as a DSB. The corresponding negative control, 8H, has the same basic structural features as 32Hc, but is

consists of a polyethylene glycol chain that is inert and stable in living systems. The resulting molecules are very stable, with melting temperatures of about 85 to 90◦C, despite their small size (between 16 and 64 bp). They are resistant to incubation for six hours with serum or cell extract (unpublished data). Like most nucleic acid-based molecules, siDNAs penetrate cells poorly and complexing with transfection agents (Patil et al., 2005) or lipophilic molecules (Rossi, 2004) is required for efficient entry. Three classes of molecules have already been tested: molecules mimicking double-strand breaks (Dbait), molecules mimicking single-strand breaks (Pbait) and molecules mimicking single-strand DNA stretches (Sbait). An example of the structure of a Dbait molecule is provided in Figure 4. Every siDNA is

too short to bind the central NHEJ components. B, base.

recognized by specific sensors and triggers a corresponding partial DDR.

damage and are not degraded, replicated or repaired in the cell.

**4.1 SiDNA: principle and properties**

In addition to the membrane-bound TLR9, cytosolic DNA sensors have recently been identified (Yanai et al., 2009). These sensors include TREX1, DNA-dependent activator of interferon regulatory factors (DAI) and a DNA-sensing inflammasome containing absent in melanoma 2 (AIM2). This protein belongs to the HIN-200 family and is a cytoplasmic sensor mediating caspase 1 activation in response to cytoplasmic dsDNA (Burckstummer et al., 2009; Fernandes-Alnemri et al., 2009; Hornung et al., 2009). Another cytosolic DNA sensor and activator of innate immune responses, DAI (also known as DLM-1 and Z-DNA binding protein 1), has also recently been identified (Takaoka et al., 2007). DAI binds dsDNA, leading to its association with the IRF3 transcription factor and the TBK1 serine/threonine kinase, resulting in a signaling cascade that culminates in NF*κ*B activation. The activation of interferon responses is restricted by the length of the DNA, with little activation observed in response to DNA molecules of less than 100 bp in length, suggesting that DAI activation requires the formation of a multimeric complex over long stretches of DNA (Takaoka & Taniguchi, 2008).

Several studies have identified the 3'→5' DNA exonuclease DNaseIII/TREX1 as associated with autoimmune and inflammatory diseases in humans (Crow et al., 2006; Lee-Kirsch et al., 2007). TREX1 is a regulator of DNA homeostasis in the cell and has been reported to counteract the activation of ATM by small ssDNA fragments (section 3.1). Indeed, in the absence of TREX1, 60-65 bp ssDNA polynucleotides accumulate, leading to chronic ATM-dependent DNA damage checkpoint signaling (Yang et al., 2007). Thus, TREX1 is not itself a DNA sensor. Instead, it regulates the accumulation of the ssDNA that can trigger an innate immune response. In addition to linking a DDR factor to the immune response, these findings demonstrate that immune responses may be triggered not only by foreign DNA, but also by self-derived DNA.

The most prominent protein involved in both the DDR and the immune response, in addition to TREX1, is DNA-PKcs. In addition to its long known role in V(D)J recombination in developing lymphocytes (Jeggo et al., 1995), DNA-PKcs has also been reported to phosphorylate IFN regulatory factor-3 (IRF-3) directly (Karpova et al., 2002). IRF-3 plays a key role in the host response to viral infection, and its phosphorylation by DNA-PK after viral infection results in its nuclear retention and delayed proteolysis. Another study has suggested that DNA-PKcs mediates Akt activation in response to CpG-DNA in bone marrow-derived macrophages (BMDMs) (Dragoi et al., 2005). In BMDMs, DNA-PKcs associates with Akt upon CpG-DNA stimulation, thereby triggering the nuclear translocation of Akt. It has been suggested that TLR9 is involved in this pathway, but its possible role remains a matter of debate (Dragoi et al., 2005; Sester et al., 2006). The CpG-DNA/DNAPKcs/Akt pathway may account for the induction, by CpG-DNA and synthetic CpG oligonucleotides, of prosurvival signals delivered to the immune system (Dragoi et al., 2005; Park et al., 2002).

#### **4. Signal interfering DNA (siDNA)**

As summarized in Figures 1 and 2, difficulties attributing the activation of a specific transducer to a specific type of damage *in vivo* result principally from the multiple type of damage induced by a single treatment, through the mechanism of action of the treatment and metabolism of the initial damage through replication and repair. Moreover, the large DNA molecules sometimes used to induce a damage response (see section 3.1) probably contain sequences recognized by specific proteins that may interfere with DNA damage recognition and repair. We recently tried to overcome these problems by proposing the use of a new class of small molecules (siDNA, for small interfering DNA) each mimicking one particular type of damage and are not degraded, replicated or repaired in the cell.

#### **4.1 SiDNA: principle and properties**

18 Will-be-set-by-IN-TECH

In addition to the membrane-bound TLR9, cytosolic DNA sensors have recently been identified (Yanai et al., 2009). These sensors include TREX1, DNA-dependent activator of interferon regulatory factors (DAI) and a DNA-sensing inflammasome containing absent in melanoma 2 (AIM2). This protein belongs to the HIN-200 family and is a cytoplasmic sensor mediating caspase 1 activation in response to cytoplasmic dsDNA (Burckstummer et al., 2009; Fernandes-Alnemri et al., 2009; Hornung et al., 2009). Another cytosolic DNA sensor and activator of innate immune responses, DAI (also known as DLM-1 and Z-DNA binding protein 1), has also recently been identified (Takaoka et al., 2007). DAI binds dsDNA, leading to its association with the IRF3 transcription factor and the TBK1 serine/threonine kinase, resulting in a signaling cascade that culminates in NF*κ*B activation. The activation of interferon responses is restricted by the length of the DNA, with little activation observed in response to DNA molecules of less than 100 bp in length, suggesting that DAI activation requires the formation of a multimeric complex over long stretches of DNA (Takaoka &

Several studies have identified the 3'→5' DNA exonuclease DNaseIII/TREX1 as associated with autoimmune and inflammatory diseases in humans (Crow et al., 2006; Lee-Kirsch et al., 2007). TREX1 is a regulator of DNA homeostasis in the cell and has been reported to counteract the activation of ATM by small ssDNA fragments (section 3.1). Indeed, in the absence of TREX1, 60-65 bp ssDNA polynucleotides accumulate, leading to chronic ATM-dependent DNA damage checkpoint signaling (Yang et al., 2007). Thus, TREX1 is not itself a DNA sensor. Instead, it regulates the accumulation of the ssDNA that can trigger an innate immune response. In addition to linking a DDR factor to the immune response, these findings demonstrate that immune responses may be triggered not only by foreign DNA, but

The most prominent protein involved in both the DDR and the immune response, in addition to TREX1, is DNA-PKcs. In addition to its long known role in V(D)J recombination in developing lymphocytes (Jeggo et al., 1995), DNA-PKcs has also been reported to phosphorylate IFN regulatory factor-3 (IRF-3) directly (Karpova et al., 2002). IRF-3 plays a key role in the host response to viral infection, and its phosphorylation by DNA-PK after viral infection results in its nuclear retention and delayed proteolysis. Another study has suggested that DNA-PKcs mediates Akt activation in response to CpG-DNA in bone marrow-derived macrophages (BMDMs) (Dragoi et al., 2005). In BMDMs, DNA-PKcs associates with Akt upon CpG-DNA stimulation, thereby triggering the nuclear translocation of Akt. It has been suggested that TLR9 is involved in this pathway, but its possible role remains a matter of debate (Dragoi et al., 2005; Sester et al., 2006). The CpG-DNA/DNAPKcs/Akt pathway may account for the induction, by CpG-DNA and synthetic CpG oligonucleotides, of prosurvival

As summarized in Figures 1 and 2, difficulties attributing the activation of a specific transducer to a specific type of damage *in vivo* result principally from the multiple type of damage induced by a single treatment, through the mechanism of action of the treatment and metabolism of the initial damage through replication and repair. Moreover, the large DNA molecules sometimes used to induce a damage response (see section 3.1) probably contain sequences recognized by specific proteins that may interfere with DNA damage recognition

signals delivered to the immune system (Dragoi et al., 2005; Park et al., 2002).

Taniguchi, 2008).

also by self-derived DNA.

**4. Signal interfering DNA (siDNA)**

We initially designed and tested only a few classes of siDNA molecules, to provide proof-of-concept for this approach. However, this concept can be extended to any specific type of damage. An siDNA is a small nucleic acid molecule carrying a modification recognized as a lesion by the sensor and transducer proteins. In addition to mimicking a specific type of damage, siDNA molecules must (i) be resistant to the action of nucleases, (ii) be as small as possible, to minimize the formation of secondary structures or degradation products, (iii) have no specific sequence likely to be recognized by DNA-binding proteins, such as transcription factors, (iv) mimic one single type of damage, ideally one that cannot be processed and (v) be recognized by at least one molecule involved in the DDR. SiDNAs are oligonucleotides chemically synthesized on solid support, by cycles of nucleotide addition. They are protected from exonuclease degradation by three phosphorothioate groups at the free 3' and 5' ends. Most siDNA molecules are double-stranded and have a specific modification characteristic of one type of damage. Dissociation of the short duplex is prevented by a linker tethering the two complementary strands at one or both ends of the molecule. The linker molecule

Fig. 4. Structure of the DSB-mimicking Dbait. Dbait 32Hc is a 32 bp DNA molecule tethered to its complementary sequence by a hexaethylene glycol loop (blue half circle) at one end and protected against exonuclease by phosphorothioate nucleotides (asterisks, phosphorothioate bond highlighted in red) at the other end. In the name 32Hc, H stands for hexaethylene glycol and c refers to the sequence. The sequence is not important for recognition as a DSB. The corresponding negative control, 8H, has the same basic structural features as 32Hc, but is too short to bind the central NHEJ components. B, base.

consists of a polyethylene glycol chain that is inert and stable in living systems. The resulting molecules are very stable, with melting temperatures of about 85 to 90◦C, despite their small size (between 16 and 64 bp). They are resistant to incubation for six hours with serum or cell extract (unpublished data). Like most nucleic acid-based molecules, siDNAs penetrate cells poorly and complexing with transfection agents (Patil et al., 2005) or lipophilic molecules (Rossi, 2004) is required for efficient entry. Three classes of molecules have already been tested: molecules mimicking double-strand breaks (Dbait), molecules mimicking single-strand breaks (Pbait) and molecules mimicking single-strand DNA stretches (Sbait). An example of the structure of a Dbait molecule is provided in Figure 4. Every siDNA is recognized by specific sensors and triggers a corresponding partial DDR.

the cytoplasm and modify the targets present in this compartment (Quanz et al., submitted, Figure 5). The lack of coordination of target modifications at the site of DNA damage prevents

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 353

Fig. 5. Differential cytoplasmic and nuclear transducer activation by different siDNAs. Both Dbait and Sbait treatment lead to the phosphorylation of H2AX (green, top) and Hsp90*α* (green, middle) and induce a PARylation signal (green, bottom). Unlike Sbait, Dbait is already recognized in the cytoplasm, inducing cytoplasmic Hsp90*α* phosphorylation and a cytoplasmic PARylation signal. Pbait, which activates only PARP, induces PARylation but not the phosphorylation of H2AX or Hsp90*α*. The negative control is an siDNA molecule that is too short to recruit and activate DNA damage transducers. The cell nuclei are shown in blue. the further accumulation of DNA repair proteins at repair foci at these sites (Quanz et al., 2009b). For example, in cells treated with Dbait, DNA-PK autophosphorylation is detected in both the cytoplasm and the nucleus and H2AX is phosphorylated along the length of the chromosome. After the irradiation of Dbait-treated cells, repair proteins, such as Nbs1, 53BP1, Rad51, do not relocate to sites of damage or form repair foci. However, despite their incapacity to form repair foci, irradiated siDNA-treated cells display a complete DDR response, with the

The disturbance of the spatiotemporal organization of the DDR by siDNA leads to inhibition of the formation of repair foci after irradiation. Cells treated with Dbait or Pbait are therefore sensitive to IR or other DNA damaging agents. Irradiated DNA is repaired with two-component kinetics. Most of the damage is repaired rapidly, with no significant effect of Dbait treatment. By contrast, the repair of the residual damage (15-20%), which takes longer, is strongly affected by Dbait treatment (Quanz et al., Figure 6). The slowly repaired damage is thought to correspond to DSBs with complex ends (Riballo et al., 2004) and/or to be predominantly located at the periphery of genomic heterochromatin, in regions of condensed chromatin (Goodarzi et al., 2010; Mosesso et al., 2010). As a consequence of the inhibition of repair, cells treated with Dbait are highly sensitive to irradiation. This property has been used *in vivo* in the development of new drugs for treating radioresistant tumors. DT01, a clinical product from the Dbait class of siDNAs, increases the survival of nude mice xenografted with radioresistant melanoma (Quanz et al., 2009a). DT01 efficacy is strictly dependent on the dose

induction of apoptosis (Quanz et al., 2009b).

**4.4 SiDNAs inhibit DNA repair**

#### **4.2 SiDNAs induce specific, stable and persistent damage responses**

PIKKs and PARP enzymes are thought to be the first transducers activated by DNA damage. We threfore monitored the cellular response induced by siDNAs by detecting the modification of the downstream targets of these enzymes in cells. Using mutant cells defective in the various enzymes, we showed that Dbait activated DNA-PK and PARP, Pbait activated only PARP and Sbait activated only ATM ((Quanz et al., 2009b); to be published). These transducer activations resulted in the posttranslational modification of all known targets of these enzymes investigated. For example, Dbait induces the phosphorylation of H2AX, RPA, p53, Nbs1, Chk1, Chk2, DNA-PK, ATM, Hsp90*α*, and the PARylation of a broad number of proteins. Interestingly, ATM which is also thought to be activated by DSBs, was not activated by Dbait or Pbait, but exclusively by Sbait molecules, which are single-stranded. This is consistent with the model in which DSBs must be partially degraded to activate ATM, as described above. The association of Mre11 with Rad50 and Nbs1 stimulates its endonuclease and exonuclease activities, resulting in the processing of DSB ends, leading to the generation of overhanging ssDNA regions (Paull & Gellert, 1998; 1999). Our results show that DSBs do not directly activate ATM if they remain unprocessed.

The posttranslational modifications induced by the siDNA-mediated activation of transducers persist for more than 24 hours in the cells. Phosphorylated or PARylated effectors have been detected more than one day after treatment and their persistence in cells depends on the turnover rate of the modified protein and the rate of cell division (Quanz et al., 2009b). Phosphorylated histone H2AX, for instance, was detected up to five days after treatment with Dbait, when Dbait molecules were no longer present in the cell. Similar results were obtained for other effectors, suggesting that siDNAs do not induce feedback control mechanisms ensuring the rapid return of cells to an "unactivated" state when repair is completed. At least three phosphatases, protein phosphatase 2A (PP2A), wild-type p53-induced phosphatase (Wip1) and protein phosphatase 5 (PP5), are involved in the DDR. It remains unclear how these phosphatases are activated during DDR, but they are instrumental in ATM activation (Ali et al., 2004; Goodarzi et al., 2004; Shreeram et al., 2006). The results of studies of unrepairable siDNAs suggest that the phosphatases or the proteasome must be activated by a "successful repair" signal instead, rather than simply removing phosphates or the modified proteins as a part of an equilibrium.

#### **4.3 Transducer activation by siDNA is not sufficient to induce complete DDR**

Although transducers are fully activated and all their molecular targets seem to be modified, the siDNAs Dbait and Pbait do not trigger the major end-points of the DDR response: cell-cycle arrest and apoptosis. In the absence of genotoxic or other stresses, cells with strong siDNA responses continue to divide at the same rate as untreated cells and do not enter apoptosis (Quanz et al., 2009b). This suggests that the DDR requires a correct spatio-temporal organization and/or more than a single damage signaling input for full execution. This is consistent with the model described above, in which redundant pathways may control the risk of erroneous signaling in cells (Yarosh, 2001). According to this hypothesis, the signal resulting from one siDNA treatment would not be sufficient to trigger a complete DDR response.

SiDNAs also differ from chromosomal DNA damage in their location and the timing of the different activation processes. SiDNAs constitute an artificial form of damage outside the context of chromatin and able to cross the cytoplasm, which contains a subset of effectors and transducers, such as DNA-PK and PARP. These signaling enzymes are therefore activated in 20 Will-be-set-by-IN-TECH

PIKKs and PARP enzymes are thought to be the first transducers activated by DNA damage. We threfore monitored the cellular response induced by siDNAs by detecting the modification of the downstream targets of these enzymes in cells. Using mutant cells defective in the various enzymes, we showed that Dbait activated DNA-PK and PARP, Pbait activated only PARP and Sbait activated only ATM ((Quanz et al., 2009b); to be published). These transducer activations resulted in the posttranslational modification of all known targets of these enzymes investigated. For example, Dbait induces the phosphorylation of H2AX, RPA, p53, Nbs1, Chk1, Chk2, DNA-PK, ATM, Hsp90*α*, and the PARylation of a broad number of proteins. Interestingly, ATM which is also thought to be activated by DSBs, was not activated by Dbait or Pbait, but exclusively by Sbait molecules, which are single-stranded. This is consistent with the model in which DSBs must be partially degraded to activate ATM, as described above. The association of Mre11 with Rad50 and Nbs1 stimulates its endonuclease and exonuclease activities, resulting in the processing of DSB ends, leading to the generation of overhanging ssDNA regions (Paull & Gellert, 1998; 1999). Our results show that DSBs do

The posttranslational modifications induced by the siDNA-mediated activation of transducers persist for more than 24 hours in the cells. Phosphorylated or PARylated effectors have been detected more than one day after treatment and their persistence in cells depends on the turnover rate of the modified protein and the rate of cell division (Quanz et al., 2009b). Phosphorylated histone H2AX, for instance, was detected up to five days after treatment with Dbait, when Dbait molecules were no longer present in the cell. Similar results were obtained for other effectors, suggesting that siDNAs do not induce feedback control mechanisms ensuring the rapid return of cells to an "unactivated" state when repair is completed. At least three phosphatases, protein phosphatase 2A (PP2A), wild-type p53-induced phosphatase (Wip1) and protein phosphatase 5 (PP5), are involved in the DDR. It remains unclear how these phosphatases are activated during DDR, but they are instrumental in ATM activation (Ali et al., 2004; Goodarzi et al., 2004; Shreeram et al., 2006). The results of studies of unrepairable siDNAs suggest that the phosphatases or the proteasome must be activated by a "successful repair" signal instead, rather than simply removing phosphates or the modified

**4.3 Transducer activation by siDNA is not sufficient to induce complete DDR**

Although transducers are fully activated and all their molecular targets seem to be modified, the siDNAs Dbait and Pbait do not trigger the major end-points of the DDR response: cell-cycle arrest and apoptosis. In the absence of genotoxic or other stresses, cells with strong siDNA responses continue to divide at the same rate as untreated cells and do not enter apoptosis (Quanz et al., 2009b). This suggests that the DDR requires a correct spatio-temporal organization and/or more than a single damage signaling input for full execution. This is consistent with the model described above, in which redundant pathways may control the risk of erroneous signaling in cells (Yarosh, 2001). According to this hypothesis, the signal resulting from one siDNA treatment would not be sufficient to trigger a complete DDR response. SiDNAs also differ from chromosomal DNA damage in their location and the timing of the different activation processes. SiDNAs constitute an artificial form of damage outside the context of chromatin and able to cross the cytoplasm, which contains a subset of effectors and transducers, such as DNA-PK and PARP. These signaling enzymes are therefore activated in

**4.2 SiDNAs induce specific, stable and persistent damage responses**

not directly activate ATM if they remain unprocessed.

proteins as a part of an equilibrium.

the cytoplasm and modify the targets present in this compartment (Quanz et al., submitted, Figure 5). The lack of coordination of target modifications at the site of DNA damage prevents

Fig. 5. Differential cytoplasmic and nuclear transducer activation by different siDNAs. Both Dbait and Sbait treatment lead to the phosphorylation of H2AX (green, top) and Hsp90*α* (green, middle) and induce a PARylation signal (green, bottom). Unlike Sbait, Dbait is already recognized in the cytoplasm, inducing cytoplasmic Hsp90*α* phosphorylation and a cytoplasmic PARylation signal. Pbait, which activates only PARP, induces PARylation but not the phosphorylation of H2AX or Hsp90*α*. The negative control is an siDNA molecule that is too short to recruit and activate DNA damage transducers. The cell nuclei are shown in blue.

the further accumulation of DNA repair proteins at repair foci at these sites (Quanz et al., 2009b). For example, in cells treated with Dbait, DNA-PK autophosphorylation is detected in both the cytoplasm and the nucleus and H2AX is phosphorylated along the length of the chromosome. After the irradiation of Dbait-treated cells, repair proteins, such as Nbs1, 53BP1, Rad51, do not relocate to sites of damage or form repair foci. However, despite their incapacity to form repair foci, irradiated siDNA-treated cells display a complete DDR response, with the induction of apoptosis (Quanz et al., 2009b).

#### **4.4 SiDNAs inhibit DNA repair**

The disturbance of the spatiotemporal organization of the DDR by siDNA leads to inhibition of the formation of repair foci after irradiation. Cells treated with Dbait or Pbait are therefore sensitive to IR or other DNA damaging agents. Irradiated DNA is repaired with two-component kinetics. Most of the damage is repaired rapidly, with no significant effect of Dbait treatment. By contrast, the repair of the residual damage (15-20%), which takes longer, is strongly affected by Dbait treatment (Quanz et al., Figure 6). The slowly repaired damage is thought to correspond to DSBs with complex ends (Riballo et al., 2004) and/or to be predominantly located at the periphery of genomic heterochromatin, in regions of condensed chromatin (Goodarzi et al., 2010; Mosesso et al., 2010). As a consequence of the inhibition of repair, cells treated with Dbait are highly sensitive to irradiation. This property has been used *in vivo* in the development of new drugs for treating radioresistant tumors. DT01, a clinical product from the Dbait class of siDNAs, increases the survival of nude mice xenografted with radioresistant melanoma (Quanz et al., 2009a). DT01 efficacy is strictly dependent on the dose

Fig. 7. The survival of xenografted animals is dependent on DT01 dose. Kaplan-Meier representation of the survival of nude mice with xenografted SK28 melanoma tumors. After two weeks of treatment, consisting of six injections of DT01 injections (arrows) at various doses and the administration of 3 Gy in 10 fractions (triangles, tumor volume was assessed.

ATM activation by ssDNA, DNA-PK activation has a much smaller impact on the cell cycle and apoptosis induction. Thus, siDNA can be used as a tool for the specific activation of individual repair signaling enzymes, making it possible to investigate specific branches of the damage response, which is not possible with conventional DNA damaging agents that induce a plethora of different lesions. A similar approach could now be used for other kinds of DNA damage, to check for activation of the corresponding downstream repair pathways in cells. This should make it possible to answer currently unresolved questions, concerning the impact of PARP-signaling or mismatch-signaling on cell fate, for example. This should not only deepen our understanding of the specific pathways activated in response to a particular type of damage, but should also be useful in cancer treatment. The "jamming" of specific repair signaling pathways may help to overcome resistance to treatment and to enhance the

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 355

We apologize to the many groups whose primary research papers could not be cited owing to space constraints. Work in the authors' laboratory was supported by Institut Curie, CNRS,

The ethical limit for tumor volume was 2000 mm3. NT: untreated control group.

response to cancer treatments targeting DNA.

INSERM, and ANR grant ANR-08-Biot-009-02.

**6. Acknowledgments**

Fig. 6. Dbait inhibits slow DNA repair. MRC5 cells transfected or not transfected with Dbait were irradiated with 8 Gy. DNA damage repair was followed by alkaline comet assays over a period of 60 min.

administered (Figure 7) and is independent of the associated radiotherapy protocol. A phase I/II clinical trial will be initiated in 2011, to assess the efficacy of a treatment combining DT01 and radiotherapy for the treatment of local metastases of melanoma.

#### **5. Conclusion**

The study of DNA repair is a complicated task, due to the diversity of damage induced by DNA-damaging agents and the subsequent conversion of the damage by repair pathways or the DNA replication machinery. Furthermore, the damage may be repaired by different repair pathways, depending on the phase of the cell cycle at the time of damage. Finally, if the damage to the chromosome is too extensive, the cell undergoes apoptosis or senescence. The use of different techniques to induce a specific type of damage in the absence of chromosomal DNA damage within the cell has greatly contributed to our understandings of individual repair pathways. The tethering of repair proteins has demonstrated that the local concentration of damage signaling factors is sufficient to trigger a full damage response, independently of the presence of actual cellular damage. Consistent with this, agents modifying chromatin topology can induce DNA damage transducer activity in the absence of DNA lesions. Studies of the recognition of viral genomic material have contributed to our understanding of the cellular DDR. For example, studies of adenovirus interference with damage signaling through degradation of the MRN complex have suggested that MRN plays an upstream role in damage detection. Synthetic ICL constructs, introduced into cells on plasmids, have proved a useful tool for investigating this specific type of DNA damage. This approach made it possible to demonstrate the contribution of the Fanconi anemia pathway to the repair of ICLs. Studies based on the use of DNA fragments have identified ssDNA as the universal signal of the ATM-induced DDR. The introduction into cells of small double-stranded siDNA molecules, which are resistant to exonuclease attack and repair , has made it possible to demonstrate that DSBs alone activate DNA-PK only, leading to the phosphorylation of a multitude of downstream targets. However, unlike 22 Will-be-set-by-IN-TECH

Fig. 6. Dbait inhibits slow DNA repair. MRC5 cells transfected or not transfected with Dbait were irradiated with 8 Gy. DNA damage repair was followed by alkaline comet assays over a

administered (Figure 7) and is independent of the associated radiotherapy protocol. A phase I/II clinical trial will be initiated in 2011, to assess the efficacy of a treatment combining DT01

The study of DNA repair is a complicated task, due to the diversity of damage induced by DNA-damaging agents and the subsequent conversion of the damage by repair pathways or the DNA replication machinery. Furthermore, the damage may be repaired by different repair pathways, depending on the phase of the cell cycle at the time of damage. Finally, if the damage to the chromosome is too extensive, the cell undergoes apoptosis or senescence. The use of different techniques to induce a specific type of damage in the absence of chromosomal DNA damage within the cell has greatly contributed to our understandings of individual repair pathways. The tethering of repair proteins has demonstrated that the local concentration of damage signaling factors is sufficient to trigger a full damage response, independently of the presence of actual cellular damage. Consistent with this, agents modifying chromatin topology can induce DNA damage transducer activity in the absence of DNA lesions. Studies of the recognition of viral genomic material have contributed to our understanding of the cellular DDR. For example, studies of adenovirus interference with damage signaling through degradation of the MRN complex have suggested that MRN plays an upstream role in damage detection. Synthetic ICL constructs, introduced into cells on plasmids, have proved a useful tool for investigating this specific type of DNA damage. This approach made it possible to demonstrate the contribution of the Fanconi anemia pathway to the repair of ICLs. Studies based on the use of DNA fragments have identified ssDNA as the universal signal of the ATM-induced DDR. The introduction into cells of small double-stranded siDNA molecules, which are resistant to exonuclease attack and repair , has made it possible to demonstrate that DSBs alone activate DNA-PK only, leading to the phosphorylation of a multitude of downstream targets. However, unlike

and radiotherapy for the treatment of local metastases of melanoma.

period of 60 min.

**5. Conclusion**

Fig. 7. The survival of xenografted animals is dependent on DT01 dose. Kaplan-Meier representation of the survival of nude mice with xenografted SK28 melanoma tumors. After two weeks of treatment, consisting of six injections of DT01 injections (arrows) at various doses and the administration of 3 Gy in 10 fractions (triangles, tumor volume was assessed. The ethical limit for tumor volume was 2000 mm3. NT: untreated control group.

ATM activation by ssDNA, DNA-PK activation has a much smaller impact on the cell cycle and apoptosis induction. Thus, siDNA can be used as a tool for the specific activation of individual repair signaling enzymes, making it possible to investigate specific branches of the damage response, which is not possible with conventional DNA damaging agents that induce a plethora of different lesions. A similar approach could now be used for other kinds of DNA damage, to check for activation of the corresponding downstream repair pathways in cells. This should make it possible to answer currently unresolved questions, concerning the impact of PARP-signaling or mismatch-signaling on cell fate, for example. This should not only deepen our understanding of the specific pathways activated in response to a particular type of damage, but should also be useful in cancer treatment. The "jamming" of specific repair signaling pathways may help to overcome resistance to treatment and to enhance the response to cancer treatments targeting DNA.

#### **6. Acknowledgments**

We apologize to the many groups whose primary research papers could not be cited owing to space constraints. Work in the authors' laboratory was supported by Institut Curie, CNRS, INSERM, and ANR grant ANR-08-Biot-009-02.

Brachman, E. E. & Kmiec, E. B. (2002). The 'biased' evolution of targeted gene repair, *Curr*

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 357

Brown, K. E. (2010). The expanding range of parvoviruses which infect humans, *Rev Med Virol*

Brown, K. L., Roginskaya, M., Zou, Y., Altamirano, A., Basu, A. K. & Stone, M. P. (2010).

Buck, D., Malivert, L., de Chasseval, R., Barraud, A., Fondaneche, M. C., Sanal, O., Plebani,

Cadet, J., Berger, M., Douki, T. & Ravanat, J. L. (1997). Oxidative damage to DNA: formation, measurement, and biological significance, *Rev Physiol Biochem Pharmacol* 131: 1–87. Carson, C. T., Schwartz, R. A., Stracker, T. H., Lilley, C. E., Lee, D. V. & Weitzman, M. D. (2003).

Carter, B. J. (2004). Adeno-associated virus and the development of adeno-associated virus

Chan, K. K., Zhang, Q. M. & Dianov, G. L. (2006). Base excision repair fidelity in normal and

Chapman, J. D., Reuvers, A. P., Borsa, J. & Greenstock, C. L. (1973). Chemical radioprotection

Chappell, C., Hanakahi, L. A., Karimi-Busheri, F., Weinfeld, M. & West, S. C. (2002).

Chaurushiya, M. S. & Weitzman, M. D. (2009). Viral manipulation of DNA repair and cell

Chen, A. Y., Luo, Y., Cheng, F., Sun, Y. & Qiu, J. (2010). Bocavirus infection induces

Chen, B. P., Uematsu, N., Kobayashi, J., Lerenthal, Y., Krempler, A., Yajima, H., Lobrich, M.,

Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G., Couch, F. J., Weber,

in human immunodeficiency with microcephaly, *Cell* 124(2): 287–99. Burckstummer, T., Baumann, C., Bluml, S., Dixit, E., Durnberger, G., Jahn, H., Planyavsky, M.,

inflammasome, *Nat Immunol* 10(3): 266–72.

cancer cells, *Mutagenesis* 21(3): 173–8.

vectors: a historical perspective, *Mol Ther* 10(6): 981–9.

non-homologous end joining, *EMBO J* 21(11): 2827–32.

cycle checkpoints, *DNA Repair (Amst)* 8(9): 1166–76.

Binding of the human nucleotide excision repair proteins xpa and xpc/hr23b to the 5r-thymine glycol lesion and structure of the cis-(5r,6s) thymine glycol epimer in the 5'-gtgg-3' sequence: destabilization of two base pairs at the lesion site, *Nucleic Acids*

A., Stephan, J. L., Hufnagel, M., le Deist, F., Fischer, A., Durandy, A., de Villartay, J. P. & Revy, P. (2006). Cernunnos, a novel nonhomologous end-joining factor, is mutated

Bilban, M., Colinge, J., Bennett, K. L. & Superti-Furga, G. (2009). An orthogonal proteomic-genomic screen identifies aim2 as a cytoplasmic DNA sensor for the

The mre11 complex is required for ATM activation and the g2/m checkpoint, *EMBO*

and radiosensitization of mammalian cells growing in vitro, *Radiat Res* 56(2): 291–306.

Involvement of human polynucleotide kinase in double-strand break repair by

mitochondrion-mediated apoptosis and cell cycle arrest at g2/m phase, *J Virol*

Shiloh, Y. & Chen, D. J. (2007). Ataxia telangiectasia mutated (ATM) is essential for DNA-pkcs phosphorylations at the thr-2609 cluster upon DNA double strand break,

B. L., Ashley, T., Livingston, D. M. & Scully, R. (1998). Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic

*Opin Mol Ther* 4(2): 171–6.

20(4): 231–44.

*Res* 38(2): 428–40.

*J* 22(24): 6610–20.

84(11): 5615–26.

*J Biol Chem* 282(9): 6582–7.

cells, *Mol Cell* 2(3): 317–28.

#### **7. References**


24 Will-be-set-by-IN-TECH

Ahnesorg, P., Smith, P. & Jackson, S. P. (2006). XLF interacts with the XRCC4-DNA ligase iv complex to promote DNA nonhomologous end-joining, *Cell* 124(2): 301–13. Akira, S., Uematsu, S. & Takeuchi, O. (2006). Pathogen recognition and innate immunity, *Cell*

Ali, A., Zhang, J., Bao, S., Liu, I., Otterness, D., Dean, N. M., Abraham, R. T. & Wang,

Ariumi, Y., Turelli, P., Masutani, M. & Trono, D. (2005). DNA damage sensors ATM, ATR,

Audebert, M., Salles, B. & Calsou, P. (2004). Involvement of poly(adp-ribose) polymerase-1

Bailone, A., Brandenburger, A., Levine, A., Pierre, M., Dutreix, M. & Devoret, R. (1984).

Bakkenist, C. J. & Kastan, M. B. (2003). DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation, *Nature* 421(6922): 499–506. Bandaru, V., Sunkara, S., Wallace, S. S. & Bond, J. P. (2002). A novel human DNA

Bartek, J. & Lukas, J. (2003). Chk1 and chk2 kinases in checkpoint control and cancer, *Cancer*

Bekker-Jensen, S., Lukas, C., Kitagawa, R., Melander, F., Kastan, M. B., Bartek, J. & Lukas,

Bencokova, Z., Kaufmann, M. R., Pires, I. M., Lecane, P. S., Giaccia, A. J. & Hammond,

Bianchi, V., Pontis, E. & Reichard, P. (1986). Changes of deoxyribonucleoside triphosphate

Bianco, P. R., Tracy, R. B. & Kowalczykowski, S. C. (1998). DNA strand exchange proteins: a

Boiteux, S. & Radicella, J. P. (2000). The human ogg1 gene: structure, functions, and its implication in the process of carcinogenesis, *Arch Biochem Biophys* 377(1): 1–8. Bonilla, C. Y., Melo, J. A. & Toczyski, D. P. (2008). Colocalization of sensors is sufficient

Bonner, W. M., Redon, C. E., Dickey, J. S., Nakamura, A. J., Sedelnikova, O. A., Solier, S. & Pommier, Y. (2008). Gammah2ax and cancer, *Nat Rev Cancer* 8(12): 957–67. Bouchard, V. J., Rouleau, M. & Poirier, G. G. (2003). Parp-1, a determinant of cell survival in

biochemical and physical comparison, *Front Biosci* 3: D570–603.

response to DNA damage, *Exp Hematol* 31(6): 446–54.

Antman, K. & Chang, Y. (2000). Kaposi's sarcoma, *N Engl J Med* 342(14): 1027–38.

X. F. (2004). Requirement of protein phosphatase 5 in DNA-damage-induced ATM

DNA-pkcs, and parp-1 are dispensable for human immunodeficiency virus type 1

and xrcc1/DNA ligase iii in an alternative route for DNA double-strand breaks

Indirect sos induction is promoted by ultraviolet light-damaged minif and requires

glycosylase that removes oxidative DNA damage and is homologous to escherichia

J. (2006). Spatial organization of the mammalian genome surveillance machinery in

E. M. (2009). ATM activation and signaling under hypoxic conditions, *Mol Cell Biol*

pools induced by hydroxyurea and their relation to DNA synthesis, *J Biol Chem*

to activate the DNA damage checkpoint in the absence of damage, *Mol Cell*

**7. References**

124(4): 783–801.

*Cell* 3(5): 421–9.

29(2): 526–37.

30(3): 267–76.

261(34): 16037–42.

activation, *Genes Dev* 18(3): 249–54.

integration, *J Virol* 79(5): 2973–8.

rejoining, *J Biol Chem* 279(53): 55117–26.

the minif lyna locus, *J Mol Biol* 179(3): 367–90.

coli endonuclease viii, *DNA Repair (Amst)* 1(7): 517–29.

response to DNA strand breaks, *J Cell Biol* 173(2): 195–206.


Delale, T., Paquin, A., Asselin-Paturel, C., Dalod, M., Brizard, G., Bates, E. E., Kastner,

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 359

Dragoi, A. M., Fu, X., Ivanov, S., Zhang, P., Sheng, L., Wu, D., Li, G. C. & Chu, W. M.

D'Silva, I., Pelletier, J. D., Lagueux, J., D'Amours, D., Chaudhry, M. A., Weinfeld, M.,

Duncan, T., Trewick, S. C., Koivisto, P., Bates, P. A., Lindahl, T. & Sedgwick, B. (2002). Reversal

Durocher, D. & Jackson, S. P. (2001). DNA-PK, ATM and ATR as sensors of DNA damage:

Essers, J., Houtsmuller, A. B., van Veelen, L., Paulusma, C., Nigg, A. L., Pastink, A.,

Fernandes-Alnemri, T., Yu, J. W., Datta, P., Wu, J. & Alnemri, E. S. (2009). Aim2

Fernandez-Capetillo, O., Celeste, A. & Nussenzweig, A. (2003). Focusing on foci: H2AX and the recruitment of DNA-damage response factors, *Cell Cycle* 2(5): 426–7. Ferrara, L. & Kmiec, E. B. (2006). Targeted gene repair activates chk1 and chk2 and stalls

Fortini, P. & Dogliotti, E. (2007). Base damage and single-strand break repair: mechanisms

Fragkos, M., Breuleux, M., Clement, N. & Beard, P. (2008). Recombinant adeno-associated viral vectors are deficient in provoking a DNA damage response, *J Virol* 82(15): 7379–87. Friedberg, E. C. (1995). *DNA repair and mutagenesis*, American Society for Microbiology,

Friedberg, E. C. (2001). How nucleotide excision repair protects against cancer, *Nat Rev Cancer*

Fugmann, S. D., Lee, A. I., Shockett, P. E., Villey, I. J. & Schatz, D. G. (2000). The rag proteins

Geoffroy, M. C. & Salvetti, A. (2005). Helper functions required for wild type and recombinant

adeno-associated virus growth, *Curr Gene Ther* 5(3): 265–71.

and v(d)j recombination: complexes, ends, and transposition, *Annu Rev Immunol*

variations on a theme?, *Curr Opin Cell Biol* 13(2): 225–31.

replication in corrected cells, *DNA Repair (Amst)* 5(4): 422–31.

repair proteins, *Cell* 136(3): 435–46.

*Biochim Biophys Acta* 1430(1): 119–26.

*J* 24(4): 779–89.

99(26): 16660–5.

21(8): 2030–7.

458(7237): 509–13.

*(Amst)* 6(4): 398–409.

Washington, DC.

1(1): 22–33.

18: 495–527.

P., Chan, S., Akira, S., Vicari, A., Biron, C. A., Trinchieri, G. & Briere, F. (2005). Myd88-dependent and -independent murine cytomegalovirus sensing for ifn-alpha release and initiation of immune responses in vivo, *J Immunol* 175(10): 6723–32. Doil, C., Mailand, N., Bekker-Jensen, S., Menard, P., Larsen, D. H., Pepperkok, R., Ellenberg,

J., Panier, S., Durocher, D., Bartek, J., Lukas, J. & Lukas, C. (2009). Rnf168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of

(2005). DNA-pkcs, but not tlr9, is required for activation of akt by cpg-DNA, *EMBO*

Lees-Miller, S. P. & Poirier, G. G. (1999). Relative affinities of poly(adp-ribose) polymerase and DNA-dependent protein kinase for DNA strand interruptions,

of DNA alkylation damage by two human dioxygenases, *Proc Natl Acad Sci U S A*

Vermeulen, W., Hoeijmakers, J. H. & Kanaar, R. (2002). Nuclear dynamics of rad52 group homologous recombination proteins in response to DNA damage, *EMBO J*

activates the inflammasome and cell death in response to cytoplasmic DNA, *Nature*

and functional significance of short- and long-patch repair subpathways, *DNA Repair*


26 Will-be-set-by-IN-TECH

Choi, Y. K., Nash, K., Byrne, B. J., Muzyczka, N. & Song, S. (2010). The effect of

Cleaver, J. E. (2005). Cancer in xeroderma pigmentosum and related disorders of DNA repair,

Collaco, R. F., Bevington, J. M., Bhrigu, V., Kalman-Maltese, V. & Trempe, J. P. (2009).

Cornelis, J. J., Su, Z. Z. & Rommelaere, J. (1982). Direct and indirect effects of ultraviolet light on the mutagenesis of parvovirus h-1 in human cells, *EMBO J* 1(6): 693–9. Costanzo, V., Paull, T., Gottesman, M. & Gautier, J. (2004). Mre11 assembles linear DNA fragments into DNA damage signaling complexes, *PLoS Biol* 2(5): E110. Craig, N. L. & Roberts, J. W. (1981). Function of nucleoside triphosphate and polynucleotide

Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van

Daniel, R., Katz, R. A. & Skalka, A. M. (1999). A role for DNA-PK in retroviral

Daniel, R., Marusich, E., Argyris, E., Zhao, R. Y., Skalka, A. M. & Pomerantz, R. J. (2005).

Daniel, R., Ramcharan, J., Rogakou, E., Taganov, K. D., Greger, J. G., Bonner, W., Nussenzweig,

D'Ari, R. & Huisman, O. (1982). DNA replication and indirect induction of the sos response

Davy, C. & Doorbar, J. (2007). G2/m cell cycle arrest in the life cycle of viruses, *Virology*

De Bont, R. & van Larebeke, N. (2004). Endogenous DNA damage in humans: a review of

de Jager, M., van Noort, J., van Gent, D. C., Dekker, C., Kanaar, R. & Wyman, C. (2001). Human

rad50/mre11 is a flexible complex that can tether DNA ends, *Mol Cell* 8(5): 1129–35.

aicardi-goutieres syndrome at the ags1 locus, *Nat Genet* 38(8): 917–20. Dahl, J., You, J. & Benjamin, T. L. (2005). Induction and utilization of an ATM signaling

pathway by polyomavirus, *J Virol* 79(20): 13007–17.

(New York, N.Y.) Science. 1999 Apr 23;284(5414):644-7.

in escherichia coli, *Biochimie* 64(8-9): 623–7.

quantitative data, *Mutagenesis* 19(3): 169–85.

5(12): e15073.

*Nat Rev Cancer* 5(7): 564–73.

*Virology* 392(1): 24–33.

*Chem* 256(15): 8039–44.

cells, *J Virol* 79(4): 2058–65.

279(44): 45810–4.

368(2): 219–26.

DNA-dependent protein kinase on adeno-associated virus replication, *PLoS One*

Adeno-associated virus and adenovirus coinfection induces a cellular DNA damage and repair response via redundant phosphatidylinositol 3-like kinase pathways,

in escherichia coli reca protein-directed cleavage of phage lambda repressor, *J Biol*

Bokhoven, H., Brunner, H. G., Hamel, B. C., Corry, P. C., Cowan, F. M., Frints, S. G., Klepper, J., Livingston, J. H., Lynch, S. A., Massey, R. F., Meritet, J. F., Michaud, J. L., Ponsot, G., Voit, T., Lebon, P., Bonthron, D. T., Jackson, A. P., Barnes, D. E. & Lindahl, T. (2006). Mutations in the gene encoding the 3'-5' DNA exonuclease trex1 cause

DNA integration, *Science* 284(5414): 644–7. Daniel, R Katz, R A Skalka, A M AI40721/AI/NIAID NIH HHS/United States AI40835/AI/NIAID NIH HHS/United States CA71515/CA/NCI NIH HHS/United States etc. Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United states Science

Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing

A., Katz, R. A. & Skalka, A. M. (2004). Histone H2AX is phosphorylated at sites of retroviral DNA integration but is dispensable for postintegration repair, *J Biol Chem*


Huen, M. S., Grant, R., Manke, I., Minn, K., Yu, X., Yaffe, M. B. & Chen, J. (2007).

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 361

Ichijima, Y., Sakasai, R., Okita, N., Asahina, K., Mizutani, S. & Teraoka, H. (2005).

Igoucheva, O., Alexeev, V. & Yoon, K. (2004). Oligonucleotide-directed mutagenesis and targeted gene correction: a mechanistic point of view, *Curr Mol Med* 4(5): 445–63. Ikegami, S., Taguchi, T., Ohashi, M., Oguro, M., Nagano, H. & Mano, Y. (1978).

Iliakis, G. (2009). Backup pathways of nhej in cells of higher eukaryotes: cell cycle dependence,

Inagaki, A., Schoenmakers, S. & Baarends, W. M. (2010). DNA double strand break repair, chromosome synapsis and transcriptional silencing in meiosis, *Epigenetics* 5(4). Inagaki, K., Ma, C., Storm, T. A., Kay, M. A. & Nakai, H. (2007). The role of DNA-pkcs

Jang, E. R., Choi, J. D., Park, M. A., Jeong, G., Cho, H. & Lee, J. S. (2010). ATM modulates

Jazayeri, A., Balestrini, A., Garner, E., Haber, J. E. & Costanzo, V. (2008).

Jeggo, P. A., Taccioli, G. E. & Jackson, S. P. (1995). Menage a trois: double strand break

Jeggo, P. & Lavin, M. F. (2009). Cellular radiosensitivity: how much better do we understand

Johnson, R. D. & Jasin, M. (2000). Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells, *EMBO J* 19(13): 3398–407.

Karpova, A. Y., Trost, M., Murray, J. M., Cantley, L. C. & Howley, P. M. (2002). Interferon

Kastan, M. B. & Bartek, J. (2004). Cell-cycle checkpoints and cancer, *Nature* 432(7015): 316–23. Kilzer, J. M., Stracker, T., Beitzel, B., Meek, K., Weitzman, M. & Bushman, F. D. (2003). Roles of host cell factors in circularization of retroviral DNA, *Virology* 314(1): 460–7. Kim, W. J., Rajasekaran, B. & Brown, K. D. (2007). Mlh1- and ATM-dependent

n-methyl-n'-nitro-n'-nitrosoguanidine, *J Biol Chem* 282(44): 32021–31. Kim, Y. C., Gerlitz, G., Furusawa, T., Catez, F., Nussenzweig, A., Oh, K. S., Kraemer, K. H.,

occurring before induction of DNA damage, *Nat Cell Biol* 11(1): 92–6.

regulatory factor-3 is an in vivo target of DNA-PK, *Proc Natl Acad Sci U S A*

mapk signaling is activated through c-abl in response to the alkylator

Shiloh, Y. & Bustin, M. (2009). Activation of ATM depends on chromatin interactions

Jungmichel, S. & Stucki, M. (2010). Mdc1: The art of keeping things in focus, *Chromosoma* . Jurvansuu, J., Raj, K., Stasiak, A. & Beard, P. (2005). Viral transport of DNA damage that

protein assembly, *Cell* 131(5): 901–14.

response, *Biochem Biophys Res Commun* 336(3): 807–12.

polymerase-alpha, *Nature* 275(5679): 458–60.

response, *Exp Mol Med* 42(3): 195–204.

it?, *Int J Radiat Biol* 85(12): 1061–81.

that stimulate ATM activity, *Embo J* 27(14): 1953–62.

mimics a stalled replication fork, *J Virol* 79(1): 569–80.

*Radiother Oncol* 92(3): 310–5.

81(20): 11304–21.

Nov;17(11):949-57.

99(5): 2818–23.

Rnf8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint

Phosphorylation of histone H2AX at m phase in human cells without DNA damage

Aphidicolin prevents mitotic cell division by interfering with the activity of DNA

and artemis in opening viral DNA hairpin termini in various tissues in mice, *J Virol*

transcription in response to histone deacetylase inhibition as part of its DNA damage

Mre11-rad50-nbs1-dependent processing of DNA breaks generates oligonucleotides

repair, v(d)j recombination and DNA-PK, *Bioessays* 17(11): 949–57. Bioessays. 1995


28 Will-be-set-by-IN-TECH

George, J., Devoret, R. & Radman, M. (1974). Indirect ultraviolet-reactivation of phage lambda,

Gerson, S. L. (2004). Mgmt: its role in cancer aetiology and cancer therapeutics, *Nat Rev Cancer*

Goodarzi, A. A., Jeggo, P. & Lobrich, M. (2010). The influence of heterochromatin on DNA

Goodarzi, A. A., Jonnalagadda, J. C., Douglas, P., Young, D., Ye, R., Moorhead,

Grundhoff, A. & Ganem, D. (2004). Inefficient establishment of kshv latency suggests an

Guainazzi, A. & Scharer, O. D. (2010). Using synthetic DNA interstrand crosslinks to elucidate

Guo, Z., Kozlov, S., Lavin, M. F., Person, M. D. & Paull, T. T. (2010). ATM activation by

Hanawalt, P. C. (2002). Subpathways of nucleotide excision repair and their regulation,

Hartlerode, A. J. & Scully, R. (2009). Mechanisms of double-strand break repair in somatic

Helleday, T., Lo, J., van Gent, D. C. & Engelward, B. P. (2007). DNA double-strand break repair:

Helleday, T., Petermann, E., Lundin, C., Hodgson, B. & Sharma, R. A. (2008). DNA repair pathways as targets for cancer therapy, *Nat Rev Cancer* 8(3): 193–204. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino,

Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey,

Hsiang, Y. H., Lihou, M. G. & Liu, L. F. (1989). Arrest of replication forks by drug-stabilized

Huang, L. C., Clarkin, K. C. & Wahl, G. M. (1996). Sensitivity and selectivity of the DNA

topoisomerase i-DNA cleavable complexes as a mechanism of cell killing by

damage sensor responsible for activating p53-dependent g1 arrest, *Proc Natl Acad Sci*

from mechanistic understanding to cancer treatment, *DNA Repair (Amst)* 6(7): 923–35.

K., Wagner, H., Takeda, K. & Akira, S. (2000). A toll-like receptor recognizes bacterial

D. R., Latz, E. & Fitzgerald, K. A. (2009). Aim2 recognizes cytosolic dsdna and forms a caspase-1-activating inflammasome with asc, *Nature* 458(7237): 514–8. Hornung, Veit Ablasser, Andrea Charrel-Dennis, Marie Bauernfeind, Franz Horvath, Gabor Caffrey, Daniel R Latz, Eicke Fitzgerald, Katherine A AI-065483/AI/NIAID NIH HHS/United States AI-067497/AI/NIAID NIH HHS/United States R01 AI067497-03/AI/NIAID NIH HHS/United States R01 AI067497-04/AI/NIAID NIH HHS/United States Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't England Nature Nature. 2009 Mar 26;458(7237):514-8. Epub 2009 Jan

double strand break repair: Getting the strong, silent type to relax, *DNA Repair (Amst)*

G. B., Lees-Miller, S. P. & Khanna, K. K. (2004). Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2a, *EMBO J*

additional role for continued lytic replication in kaposi sarcoma pathogenesis, *J Clin*

repair pathways and identify new therapeutic targets for cancer chemotherapy, *Cell*

*Proc Natl Acad SciUSA* 71(1): 144–7.

4(4): 296–307.

9(12): 1273–82.

23(22): 4451–61.

*Invest* 113(1): 124–36.

*Mol Life Sci* 67(21): 3683–97.

*Oncogene* 21(58): 8949–56.

DNA, *Nature* 408(6813): 740–5.

21.

oxidative stress, *Science* 330(6003): 517–21.

mammalian cells, *Biochem J* 423(2): 157–68.

camptothecin, *Cancer Res* 49(18): 5077–82.

*USA* 93(10): 4827–32.


Lilley, C. E., Carson, C. T., Muotri, A. R., Gage, F. H. & Weitzman, M. D. (2005). DNA

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 363

Lilley, C. E., Schwartz, R. A. & Weitzman, M. D. (2007). Using or abusing: viruses and the

Liu, Y. & Maizels, N. (2000). Coordinated response of mammalian rad51 and rad52 to DNA

Liu, Y. & West, S. C. (2004). Happy hollidays: 40th anniversary of the holliday junction, *Nat*

Lobrich, M. & Jeggo, P. A. (2007). The impact of a negligent g2/m checkpoint on genomic

Lopez-Contreras, A. J. & Fernandez-Capetillo, O. (2010). The ATR barrier to replication-born

Lukas, C., Falck, J., Bartkova, J., Bartek, J. & Lukas, J. (2003). Distinct spatiotemporal

Lukas, J., Lukas, C. & Bartek, J. (2004). Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time, *DNA Repair (Amst)* 3(8-9): 997–1007. Lund, J., Sato, A., Akira, S., Medzhitov, R. & Iwasaki, A. (2003). Toll-like receptor 9-mediated

Lundin, C., Erixon, K., Arnaudeau, C., Schultz, N., Jenssen, D., Meuth, M. & Helleday,

Luo, M. H., Rosenke, K., Czornak, K. & Fortunato, E. A. (2007). Human cytomegalovirus

Luo, Y., Chen, A. Y. & Qiu, J. (2011). Bocavirus infection induces a DNA damage response that facilitates viral DNA replication and mediates cell death, *J Virol* 85(1): 133–45. Ma, Y., Pannicke, U., Schwarz, K. & Lieber, M. R. (2002). Hairpin opening and

nonhomologous end joining and v(d)j recombination, *Cell* 108(6): 781–94. Malanga, M. & Althaus, F. R. (2005). The role of poly(adp-ribose) in the DNA damage

Malanga, M., Pleschke, J. M., Kleczkowska, H. E. & Althaus, F. R. (1998). Poly(adp-ribose)

Masson, C., Bury-Mone, S., Guiot, E., Saez-Cirion, A., Schoevaert-Brossault, D.,

Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., r., Hurov, K. E., Luo, J.,

signaling network, *Biochem Cell Biol* 83(3): 354–64.

responsive to DNA damage, *Science* 316(5828): 1160–6.

dynamics of mammalian checkpoint regulators induced by DNA damage, *Nat Cell*

recognition of herpes simplex virus-2 by plasmacytoid dendritic cells, *J Exp Med*

T. (2002). Different roles for nonhomologous end joining and homologous recombination following replication arrest in mammalian cells, *Mol Cell Biol*

disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-rad3-related kinase-mediated DNA damage responses during lytic infection, *J Virol* 81(4): 1934–50.

overhang processing by an artemis/DNA-dependent protein kinase complex in

binds to specific domains of p53 and alters its DNA binding functions, *J Biol Chem*

Brachet-Ducos, C., Delelis, O., Subra, F., Jeanson-Leh, L. & Mouscadet, J. F. (2007). Ku80 participates in the targeting of retroviral transgenes to the chromatin of cho

Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., Shiloh, Y., Gygi, S. P. & Elledge, S. J. (2007). ATM and ATR substrate analysis reveals extensive protein networks

cellular DNA damage response, *Trends Microbiol* 15(3): 119–26.

instability and cancer induction, *Nat Rev Cancer* 7(11): 861–9.

DNA damage, *DNA Repair (Amst)* 9(12): 1249–55.

*S A* 102(16): 5844–9.

*Biol* 5(3): 255–60.

198(3): 513–20.

22(16): 5869–78.

273(19): 11839–43.

cells, *J Virol* 81(15): 7924–32.

damage, *EMBO Rep* 1(1): 85–90.

*Rev Mol Cell Biol* 5(11): 937–44.

repair proteins affect the lifecycle of herpes simplex virus 1, *Proc Natl Acad Sci U*


30 Will-be-set-by-IN-TECH

Knipscheer, P., Raschle, M., Smogorzewska, A., Enoiu, M., Ho, T. V., Scharer,

Koch, C. A., Agyei, R., Galicia, S., Metalnikov, P., O'Donnell, P., Starostine, A., Weinfeld, M. &

Kohn, K. W. (1999). Molecular interaction map of the mammalian cell cycle control and DNA

Kohn, K. W., Pommier, Y., Kerrigan, D., Markovits, J. & Covey, J. M. (1987). Topoisomerase ii as a target of anticancer drug action in mammalian cells, *NCI Monogr* (4): 61–71. Kolas, N. K., Chapman, J. R., Nakada, S., Ylanko, J., Chahwan, R., Sweeney, F. D., Panier, S.,

Kudoh, A., Fujita, M., Zhang, L., Shirata, N., Daikoku, T., Sugaya, Y., Isomura, H., Nishiyama,

Kumagai, A., Lee, J., Yoo, H. Y. & Dunphy, W. G. (2006). Topbp1 activates the ATR-atrip

Lee, J. H. & Paull, T. T. (2004). Direct activation of the ATM protein kinase by the

Lee, J. H. & Paull, T. T. (2005). ATM activation by DNA double-strand breaks through the

Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y. A., de Silva,

Li, G. M. (1999). The role of mismatch repair in DNA damage-induced apoptosis, *Oncol Res*

Li, L., Olvera, J. M., Yoder, K. E., Mitchell, R. S., Butler, S. L., Lieber, M., Martin, S. L. &

Li, L. & Zou, L. (2005). Sensing, signaling, and responding to DNA damage: organization of the checkpoint pathways in mammalian cells, *J Cell Biochem* 94(2): 298–306.

early steps of retroviral infection, *EMBO J* 20(12): 3272–81.

Bushman, F. D. (2001). Role of the non-homologous DNA end joining pathway in the

Li, G. M. (2008). Mechanisms and functions of DNA mismatch repair, *Cell Res* 18(1): 85–98. Li, J. J. & Deshaies, R. J. (1993). Exercising self-restraint: discouraging illicit acts of s and m in

Kunkel, T. A. & Erie, D. A. (2005). DNA mismatch repair, *Annu Rev Biochem* 74: 681–710. Lau, A., Swinbank, K. M., Ahmed, P. S., Taylor, D. L., Jackson, S. P., Smith, G. C. & O'Connor,

kinase to DNA ligation by DNA ligase iv, *EMBO J* 23(19): 3874–85.

repair systems, *Mol Biol Cell* 10(8): 2703–34.

326(5960): 1698–701.

*Science* 318(5856): 1637–40.

complex, *Cell* 124(5): 943–55.

kinase, *Nat Cell Biol* 7(5): 493–500.

erythematosus, *Nat Genet* 39(9): 1065–7.

eukaryotes, *Cell* 74(2): 223–6.

mre11/rad50/nbs1 complex, *Science* 304(5667): 93–6.

mre11-rad50-nbs1 complex, *Science* 308(5721): 551–4.

280(9): 8156–63.

11(9): 393–400.

O. D., Elledge, S. J. & Walter, J. C. (2009). The fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair, *Science*

Durocher, D. (2004). XRCC4 physically links DNA end processing by polynucleotide

Mendez, M., Wildenhain, J., Thomson, T. M., Pelletier, L., Jackson, S. P. & Durocher, D. (2007). Orchestration of the DNA-damage response by the rnf8 ubiquitin ligase,

Y. & Tsurumi, T. (2005). Epstein-barr virus lytic replication elicits ATM checkpoint signal transduction while providing an s-phase-like cellular environment, *J Biol Chem*

M. J. (2005). Suppression of hiv-1 infection by a small molecule inhibitor of the ATM

U., Bailey, S. L., Witte, T., Vyse, T. J., Kere, J., Pfeiffer, C., Harvey, S., Wong, A., Koskenmies, S., Hummel, O., Rohde, K., Schmidt, R. E., Dominiczak, A. F., Gahr, M., Hollis, T., Perrino, F. W., Lieberman, J. & Hubner, N. (2007). Mutations in the gene encoding the 3'-5' DNA exonuclease trex1 are associated with systemic lupus


Perry, J. J., Yannone, S. M., Holden, L. G., Hitomi, C., Asaithamby, A., Han, S., Cooper,

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 365

Polo, S. E. & Jackson, S. P. (2011). Dynamics of DNA damage response proteins at DNA breaks:

Quanz, M., Berthault, N., Roulin, C., Roy, M., Herbette, A., Agrario, C., Alberti, C., Josserand,

Quanz, M., Chassoux, D., Berthault, N., Agrario, C., Sun, J. S. & Dutreix, M.

Raderschall, E., Golub, E. I. & Haaf, T. (1999). Nuclear foci of mammalian recombination

Radford, I. R. (1985). The level of induced DNA double-strand breakage correlates with cell killing after x-irradiation, *Int J Radiat Biol Relat Stud Phys Chem Med* 48(1): 45–54. Raschle, M., Knipscheer, P., Enoiu, M., Angelov, T., Sun, J., Griffith, J. D., Ellenberger,

Rathinam, V. A. & Fitzgerald, K. A. (2011). Innate immune sensing of DNA viruses, *Virology*

Reardon, J. T. & Sancar, A. (2005). Nucleotide excision repair, *Prog Nucleic Acid Res Mol Biol*

Riballo, E., Kuhne, M., Rief, N., Doherty, A., Smith, G. C., Recio, M. J., Reis, C., Dahm, K.,

Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H. & Poirier, G. G. (2010). Parp inhibition:

Sartori, A. A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R., Lukas, J. & Jackson, S. P. (2007). Human ctip promotes DNA end resection, *Nature* 450(7169): 509–14. Schiavone, N., Papucci, L., Luciani, P., Lapucci, A., Donnini, M. & Capaccioli, S. (2000).

Rupnik, A., Grenon, M. & Lowndes, N. (2008). The mrn complex, *Curr Biol* 18(11): R455–7. Sakurai, Y., Komatsu, K., Agematsu, K. & Matsuoka, M. (2009). DNA double strand break

Rossi, J. J. (2004). Medicine: a cholesterol connection in rnai, *Nature* 432(7014): 155–6.

a focus on protein modifications, *Genes Dev* 25(5): 409–33.

tumors to radiotherapy, *Clin Cancer Res* 15(4): 1308–16.

*Natl Acad SciUSA* 96(5): 1921–6.

interstrand crosslink repair, *Cell* 134(6): 969–80.

Parp1 and beyond, *Nat Rev Cancer* 10(4): 293–301.

mutagenesis, *Nat Rev Mol Cell Biol* 8(7): 587–94.

disorganizes DNA damage response, *PLoS One* 4(7): e6298.

13(5): 414–22.

411(2): 153–62.

79: 183–235.

P. K., Chen, D. J. & Tainer, J. A. (2006). Wrn exonuclease structure and molecular mechanism imply an editing role in DNA end processing, *Nat Struct Mol Biol*

V., Coll, J. L., Sastre-Garau, X., Cosset, J. M., Larue, L., Sun, J. S. & Dutreix, M. (2009). Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing

(2009). Hyperactivation of DNA-PK by double-strand break mimicking molecules

proteins are located at single-stranded DNA regions formed after DNA damage, *Proc*

T. E., Scharer, O. D. & Walter, J. C. (2008). Mechanism of replication-coupled DNA

Fricke, A., Krempler, A., Parker, A. R., Jackson, S. P., Gennery, A., Jeggo, P. A. & Lobrich, M. (2004). A pathway of double-strand break rejoining dependent upon ATM, artemis, and proteins locating to gamma-H2AX foci, *Mol Cell* 16(5): 715–24. Rosidi, B., Wang, M., Wu, W., Sharma, A., Wang, H. & Iliakis, G. (2008). Histone h1 functions

as a stimulatory factor in backup pathways of nhej, *Nucleic Acids Res* 36(5): 1610–23.

repair enzymes function at multiple steps in retroviral infection, *Retrovirology* 6: 114.

Induction of apoptosis and mitosis inhibition by degraded DNA lipotransfection mimicking genotoxic drug effects, *Biochem Biophys Res Commun* 270(2): 406–14. Schlacher, K. & Goodman, M. F. (2007). Lessons from 50 years of sos DNA-damage-induced


32 Will-be-set-by-IN-TECH

Mazumdar, M., Lee, J. H., Sengupta, K., Ried, T., Rane, S. & Misteli, T. (2006). Tumor formation

McAdams, H. H. & Arkin, A. (1999). It's a noisy business! genetic regulation at the nanomolar

Misteli, T. & Soutoglou, E. (2009). The emerging role of nuclear architecture in DNA repair

Moreno-Herrero, F., de Jager, M., Dekker, N. H., Kanaar, R., Wyman, C. & Dekker, C. (2005).

Mosesso, P., Palitti, F., Pepe, G., Pinero, J., Bellacima, R., Ahnstrom, G. & Natarajan,

mutated in human severe combined immune deficiency, *Cell* 105(2): 177–86. Nash, K., Chen, W., Salganik, M. & Muzyczka, N. (2009). Identification of cellular proteins that interact with the adeno-associated virus rep protein, *J Virol* 83(1): 454–69. Nichols, G. J., Schaack, J. & Ornelles, D. A. (2009). Widespread phosphorylation of histone

Nick McElhinny, S. A., Havener, J. M., Garcia-Diaz, M., Juarez, R., Bebenek, K., Kee, B. L.,

Nur, E. K. A., Li, T. K., Zhang, A., Qi, H., Hars, E. S. & Liu, L. F. (2003). Single-stranded

Orelli, B., McClendon, T. B., Tsodikov, O. V., Ellenberger, T., Niedernhofer, L. J. & Scharer,

Patil, S. D., Rhodes, D. G. & Burgess, D. J. (2005). DNA-based therapeutics and DNA delivery

Paull, T. T. & Gellert, M. (1998). The 3' to 5' exonuclease activity of mre 11 facilitates repair of

Paull, T. T. & Gellert, M. (1999). Nbs1 potentiates atp-driven DNA unwinding and endonuclease cleavage by the mre11/rad50 complex, *Genes Dev* 13(10): 1276–88. Pellegrini, L., Yu, D. S., Lo, T., Anand, S., Lee, M., Blundell, T. L. & Venkitaraman, A. R. (2002).

Peng, Y., Woods, R. G., Beamish, H., Ye, R., Lees-Miller, S. P., Lavin, M. F. & Bedford, J. S.

repair but not other DNA repair pathways, *J Biol Chem* 285(6): 3705–12. Park, Y., Lee, S. W. & Sung, Y. C. (2002). Cutting edge: Cpg DNA inhibits dendritic

phosphatidylinositide-3'-oh kinase pathway, *J Immunol* 168(1): 5–8.

systems: a comprehensive review, *Aaps J* 7(1): E61–77.

DNA double-strand breaks, *Mol Cell* 1(7): 969–79.

down-regulation of ATM, *Cancer Res* 65(5): 1670–7.

following x-irradiation of human lymphocytes, *Mutat Res* 701(1): 86–91. Moshous, D., Callebaut, I., de Chasseval, R., Corneo, B., Cavazzana-Calvo, M., Le Deist, F.,

Mesoscale conformational changes in the DNA-repair complex rad50/mre11/nbs1

A. T. (2010). Relationship between chromatin structure, DNA damage and repair

Tezcan, I., Sanal, O., Bertrand, Y., Philippe, N., Fischer, A. & de Villartay, J. P. (2001). Artemis, a novel DNA double-strand break repair/v(d)j recombination protein, is

H2AX by species c adenovirus infection requires viral DNA replication, *J Virol*

Blanco, L., Kunkel, T. A. & Ramsden, D. A. (2005). A gradient of template dependence defines distinct biological roles for family x polymerases in nonhomologous end

DNA induces ataxia telangiectasia mutant (ATM)/p53-dependent DNA damage and

O. D. (2010). The xpa-binding domain of ercc1 is required for nucleotide excision

cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the

Insights into DNA recombination from the structure of a rad51-BRCA2 complex,

(2005). Deficiency in the catalytic subunit of DNA-dependent protein kinase causes

via loss of a molecular motor protein, *Curr Biol* 16(15): 1559–64.

and genome maintenance, *Nat Rev Mol Cell Biol* 10(4): 243–54.

upon binding DNA, *Nature* 437(7057): 440–3.

scale, *Trends Genet* 15(2): 65–9.

83(12): 5987–98.

joining, *Mol Cell* 19(3): 357–66.

*Nature* 420(6913): 287–93.

apoptotic signals, *J Biol Chem* 278(14): 12475–81.


Sy, S. M., Huen, M. S. & Chen, J. (2009). Palb2 is an integral component of the BRCA

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses 367

Takaoka, A. & Taniguchi, T. (2008). Cytosolic DNA recognition for triggering innate immune

Takaoka, A., Wang, Z., Choi, M. K., Yanai, H., Negishi, H., Ban, T., Lu, Y., Miyagishi,

Toledo, L. I., Murga, M., Gutierrez-Martinez, P., Soria, R. & Fernandez-Capetillo, O. (2008).

Van Dyck, E., Stasiak, A. Z., Stasiak, A. & West, S. C. (2001). Visualization of recombination

van Heemst, D., Brugmans, L., Verkaik, N. S. & van Gent, D. C. (2004). End-joining of

Vilaysane, A. & Muruve, D. A. (2009). The innate immune response to DNA, *Semin Immunol*

Wang, X., Ohnishi, K., Takahashi, A. & Ohnishi, T. (1998). Poly(adp-ribosyl)ation is

Wang, X., Peterson, C. A., Zheng, H., Nairn, R. S., Legerski, R. J. & Li, L. (2001). Involvement of

Wang, Y., Li, H., Tang, Q., Maul, G. G. & Yuan, Y. (2008). Kaposi's sarcoma-associated

Ward, I. & Chen, J. (2004). Early events in the DNA damage response, *Curr Top Dev Biol*

Ward, I. M. & Chen, J. (2001). Histone H2AX is phosphorylated in an ATR-dependent manner

Weterings, E. & Chen, D. J. (2007). DNA-dependent protein kinase in nonhomologous end

of DNA interstrand cross-link repair, *Mol Cell Biol* 21(3): 713–20.

in response to replicational stress, *J Biol Chem* 276(51): 47759–62. Ward, J. F. (1975). Radiation-induced strand breakage in DNA, *Basic Life Sci* 5B: 471–2. Weitzman, M. D., Carson, C. T., Schwartz, R. A. & Lilley, C. E. (2004). Interactions of viruses with the cellular DNA repair machinery, *DNA Repair (Amst)* 3(8-9): 1165–73. Weitzman, M. D. & Ornelles, D. A. (2005). Inactivating intracellular antiviral responses during

joining: a lock with multiple keys?, *J Cell Biol* 179(2): 183–6.

adenovirus infection, *Oncogene* 24(52): 7686–96.

Wagner, H. (2004). The immunobiology of the tlr9 subfamily, *Trends Immunol* 25(7): 381–6. Wang, S., Guo, M., Ouyang, H., Li, X., Cordon-Cardo, C., Kurimasa, A., Chen, D. J., Fuks, Z.,

106(17): 7155–60.

448(7152): 501–5.

*Dev* 22(3): 297–302.

2(10): 905–9.

21(4): 208–14.

*Sci U S A* 97(4): 1584–8.

17(22): 2819–25.

*J Virol* 82(6): 2867–82.

63: 1–35.

responses, *Adv Drug Deliv Rev* 60(7): 847–57.

DNA-PK and XRCC4, *DNA Repair (Amst)* 3(1): 43–50.

complex required for homologous recombination repair, *Proc Natl Acad Sci U S A*

M., Kodama, T., Honda, K., Ohba, Y. & Taniguchi, T. (2007). Dai (dlm-1/zbp1) is a cytosolic DNA sensor and an activator of innate immune response, *Nature*

ATR signaling can drive cells into senescence in the absence of DNA breaks, *Genes*

intermediates produced by rad52-mediated single-strand annealing, *EMBO Rep*

blunt DNA double-strand breaks in mammalian fibroblasts is precise and requires

Ling, C. C. & Li, G. C. (2000). The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest, *Proc Natl Acad*

required for p53-dependent signal transduction induced by radiation, *Oncogene*

nucleotide excision repair in a recombination-independent and error-prone pathway

herpesvirus ori-lyt-dependent DNA replication: involvement of host cellular factors,


34 Will-be-set-by-IN-TECH

Schwartz, R. A., Carson, C. T., Schuberth, C. & Weitzman, M. D. (2009). Adeno-associated

Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J. & Livingston, D. M.

Sester, D. P., Brion, K., Trieu, A., Goodridge, H. S., Roberts, T. L., Dunn, J., Hume,

Shell, S. M., Li, Z., Shkriabai, N., Kvaratskhelia, M., Brosey, C., Serrano, M. A., Chazin,

Shimodaira, H., Yoshioka-Yamashita, A., Kolodner, R. D. & Wang, J. Y. (2003). Interaction

Skalka, A. M. & Katz, R. A. (2005). Retroviral DNA integration and the DNA damage

Smith, J., Tho, L. M., Xu, N. & Gillespie, D. A. (2010). The ATM-chk2 and ATR-chk1 pathways

Soutoglou, E. & Misteli, T. (2008). Activation of the cellular DNA damage response in the

Stewart, G. S., Panier, S., Townsend, K., Al-Hakim, A. K., Kolas, N. K., Miller, E. S., Nakada,

Stiff, T., O'Driscoll, M., Rief, N., Iwabuchi, K., Lobrich, M. & Jeggo, P. A. (2004). ATM and

Stracker, T. H., Carson, C. T. & Weitzman, M. D. (2002). Adenovirus oncoproteins inactivate the mre11-rad50-nbs1 DNA repair complex, *Nature* 418(6895): 348–52. Stracker, T. H., Cassell, G. D., Ward, P., Loo, Y. M., van Breukelen, B., Carrington-Lawrence,

Strumberg, D., Pilon, A. A., Smith, M., Hickey, R., Malkas, L. & Pommier, Y. (2000). Conversion

S., Ylanko, J., Olivarius, S., Mendez, M., Oldreive, C., Wildenhain, J., Tagliaferro, A., Pelletier, L., Taubenheim, N., Durandy, A., Byrd, P. J., Stankovic, T., Taylor, A. M. & Durocher, D. (2009). The riddle syndrome protein mediates a ubiquitin-dependent

DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing

S. D., Hamatake, R. K., van der Vliet, P. C., Weller, S. K., Melendy, T. & Weitzman, M. D. (2004). The rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication, *J Virol*

of topoisomerase i cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff, *Mol Cell Biol*

in DNA damage signaling and cancer, *Adv Cancer Res* 108: 73–112.

signaling cascade at sites of DNA damage, *Cell* 136(3): 420–34.

apoptosis response to cisplatin, *Proc Natl Acad SciUSA* 100(5): 2420–5. Shreeram, S., Hee, W. K., Demidov, O. N., Kek, C., Yamaguchi, H., Fornace, A. J., J., Anderson,

protein kinase, *J Virol* 83(12): 6269–78.

*Immunol* 177(7): 4473–80.

203(13): 2793–9.

78(1): 441–53.

20(11): 3977–87.

are initiated by DNA damage, *Cell* 90(3): 425–35.

pigmentosum group a, *J Biol Chem* 284(36): 24213–22.

response, *Cell Death Differ* 12 Suppl 1: 971–8.

radiation, *Cancer Res* 64(7): 2390–6.

absence of DNA lesions, *Science* 320(5882): 1507–10.

virus replication induces a DNA damage response coordinated by DNA-dependent

(1997). Dynamic changes of BRCA1 subnuclear location and phosphorylation state

D. A., Stacey, K. J. & Sweet, M. J. (2006). Cpg DNA activates survival in murine macrophages through tlr9 and the phosphatidylinositol 3-kinase-akt pathway, *J*

W. J., Musich, P. R. & Zou, Y. (2009). Checkpoint kinase ATR promotes nucleotide excision repair of uv-induced DNA damage via physical interaction with xeroderma

of mismatch repair protein pms2 and the p53-related transcription factor p73 in

C. W., Appella, E. & Bulavin, D. V. (2006). Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by wip1 phosphatase, *J Exp Med*


**16** 

*México*

**Parasitic Protozoan** 

*Posgrado en Ciencias Genómicas* 

**DNA Repair in Pathogenic Eukaryotic Cells:** 

Numerous external and internal DNA damaging agents can affect genetic material to produce single-strand breaks (SSB), double strand breaks (DSB), inter- and intra-strand cross-links in the form of cyclobutane pyrimidine dimers and (6-4)-photoproducts, oxidation and alkylation of bases, or formation of bulky chemical adducts. Cells possess several biological processes that act in a coordinated way to supervise DNA molecules and properly repair DNA lesions to minimize genetic information loss. This DNA repair system, which has been conserved throughout eukaryotes and prokaryotes evolution, includes various pathways that can be classified according to the type of DNA lesion they can restore: i) DSB, the most detrimental lesions of DNA, can be repaired by homologous recombination (HRR) and non-homologous end joining (NHEJ) pathways [Fleck & Nielsen, 2004]; ii) aberrant bases or nucleotides from a single strand DNA can be repaired by base excision repair (BER), nucleotide excision repair (NER) and mismatch repair (MMR) pathways using the complementary strand as template for DNA synthesis. BER mainly restores non-bulky lesions that result from bases alkylation, oxidation or deamination [Krokan et al., 1997]. The main task of NER pathway, which consists in two subpathways: global genome repair (GGR) to remove damage in the overall genome and transcription-coupled repair (TCR) to specifically repair the transcribed strand of active genes, is to eliminate photoproducts produced by ultraviolet (UV) light and other bulky lesions, such as inter- and intra-strand crosslinks [Prakash &Prakash, 2000]. MMR allows the removal of base mismatches and small insertion/deletion loops (IDL) that are formed during

The genome of protozoan parasites is continuously subjected to the effects of antiparasitic drugs and host immune system attacks, which can affect its stability and therefore parasite survival. Thus, efficient DNA maintenance mechanisms are necessary to detect and accurately repair damaged nucleotides. The fully sequenced genome of the four major human pathogens described here provides new insights into parasite biology, including molecular features of

**1. Introduction** 

the replication process [Marti et al., 2002].

**Insights from Comparative Genomics of** 

Laurence A. Marchat1,2, Mavil López-Casamichana3,

Esther Orozco3 and César López-Camarillo3  *1Escuela Nacional de Medicina y Homeopatía-IPN, Programa Institucional de Biomedicina Molecular 2Programa de Doctorado en Biotecnología en Red-IPN 3Universidad Autónoma de la Ciudad de México,* 

